
(
  (S
    (NP
      (NP (NN Optimisation))
      (PP (IN of)
        (NP
          (NP (DT the) (NN RT-PCR) (NN detection))
          (PP (IN of)
            (NP
              (ADJP (RB immunomagnetically) (VBN enriched))
              (NN carcinoma) (NNS cells))))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (NP
          (NP (JJ Immunomagnetic) (NN enrichment))
          (VP (VBN followed)
            (PP (IN by)
              (NP
                (NP (NN RT-PCR))
                (PRN (-LRB- -LRB-)
                  (NP (JJ immunobead) (NN RT-PCR))
                  (-RRB- -RRB-))))))
        (VP (VBZ is)
          (NP
            (NP (DT an) (JJ efficient) (NN methodology))
            (S
              (VP (TO to)
                (VP (VB identify)
                  (NP (JJ disseminated) (NN carcinoma) (NNS cells))
                  (PP (IN in)
                    (NP (DT the)
                      (NP (NN blood))
                      (CC and)
                      (NP (NN bone) (NN marrow))))))))))
      (. .))))

(
  (S
    (S
      (NP (DT The) (NN RT-PCR) (NNS assays))
      (VP (MD must)
        (VP (VB be)
          (ADJP (CC both)
            (ADJP (JJ specific)
              (PP (IN for)
                (NP (DT the) (NN tumor) (NNS cells))))
            (CC and)
            (ADJP (RB sufficiently) (JJ sensitive)
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP
                      (NP (NN detection))
                      (PP (IN of)
                        (NP (JJ single) (NN tumor) (NNS cells))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN developed)
          (NP
            (NP (DT a) (NN method))
            (S
              (VP (TO to)
                (VP (VB test)
                  (NP
                    (NP (NN RT-PCR) (NNS assays))
                    (PP (IN for)
                      (NP (DT any) (NN cancer)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN investigated)
            (S
              (VP (VBG using)
                (NP
                  (NP (DT a) (NN panel))
                  (PP (IN of)
                    (NP
                      (NP (NN RT-PCR) (NNS markers))
                      (ADJP (JJ suitable)
                        (PP (IN for)
                          (NP
                            (NP (DT the) (NN detection))
                            (PP (IN of)
                              (NP (NN breast) (NN cancer) (NNS cells)))))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Methods))
      (: :)
      (S
        (PP (IN In)
          (NP (DT the) (NN assay)))
        (, ,)
        (NP (DT a) (JJ single) (NN cell) (JJ line-derived) (NN tumor) (NN cell))
        (VP (VBZ is)
          (VP (VBN added)
            (PP (TO to)
              (NP
                (NP
                  (NP (CD 100) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NNS PBMNCs))
                    (-RRB- -RRB-)))
                (SBAR
                  (WHPP (IN after)
                    (WHNP (WDT which)))
                  (S
                    (S
                      (NP (NN mRNA))
                      (VP (VBZ is)
                        (VP (VBN isolated))))
                    (CC and)
                    (S
                      (NP (NN reverse))
                      (VP (VBN transcribed)
                        (PP (IN for)
                          (NP (NN RT-PCR) (NN analysis))))))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NNS PBMNCs))
        (PP (IN without)
          (NP (VBN added) (NN tumor) (NNS cells))))
      (VP (VBP are)
        (VP (VBN used)
          (PP (IN as)
            (NP (NN specificity) (NNS controls))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (ADJP (RB previously) (VBN studied))
          (NNS markers))
        (NP
          (NP
            (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor))
            (PRN (-LRB- -LRB-)
              (NP (NN EGFR))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN mammaglobin) (CD 1))
            (PRN (-LRB- -LRB-)
              (NP (NN MGB1))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
            (PRN (-LRB- -LRB-)
              (NP (NN EpCAM/TACSTD1))
              (-RRB- -RRB-)))
          (, ,)
          (NP (NN mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-))
          (, ,)
          (NP
            (NP (JJ carcinoembryonic) (NN antigen))
            (PRN (-LRB- -LRB-)
              (NP (NN CEA))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN tested))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD Two) (JJ new) (JJ epithelial-specific) (NNS markers))
        (NP
          (NP (NN ELF3))
          (CC and)
          (NP (NN EphB4))))
      (VP (VBD were)
        (ADVP (RB also))
        (VP (VBN tested))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (NP (NN MUC1))
        (VP (VBD was)
          (NP (NN unsuitable))
          (SBAR (IN as)
            (S
              (NP (JJ strong) (NN amplification))
              (VP (VBD was)
                (VP (VBN detected)
                  (PP (IN in)
                    (NP (CD 100) (NN cell) (NN PBMNC) (NNS controls)))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP
            (NP (NN ELF3))
            (, ,)
            (NP (NN EphB4))
            (, ,)
            (NP (NN EpCAM))
            (, ,)
            (NP (NN EGFR))
            (, ,)
            (NP (NN CEA))
            (CC and)
            (NP (NN MGB1)))))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB be)
                (ADJP (CC both)
                  (ADJP (JJ specific)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN tumor) (NN cell))
                        (, ,)
                        (SBAR (IN as)
                          (S
                            (VP (VBN demonstrated)
                              (PP (IN by)
                                (NP
                                  (NP (DT the) (NN absence))
                                  (PP (IN of)
                                    (NP
                                      (NP (DT a) (NN signal))
                                      (PP (IN in)
                                        (NP
                                          (QP (JJS most) (CD 100))
                                          (NN cell) (NN PBMNC) (NNS controls))))))))))
                        (, ,))))
                  (CC and)
                  (ADJP (JJ sensitive)))
                (S
                  (ADVP (RB enough))
                  (VP (TO to)
                    (VP (VB detect)
                      (NP
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))
                        (PP (IN in)
                          (NP
                            (NP (CD 100) (NNS PBMNCs))
                            (VP (VBG using)
                              (NP
                                (NP (DT a) (JJ single) (NN round))
                                (PP (IN of)
                                  (NP (NN RT-PCR)))))))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Conclusions))
      (: :)
      (S
        (NP
          (NP (NN ELF3))
          (, ,)
          (NP (NN EphB4))
          (, ,)
          (NP (NN EpCAM))
          (, ,)
          (NP (NN EGFR))
          (, ,)
          (NP (NN CEA))
          (CC and)
          (NP (NN MGB1)))
        (VP (VBP are)
          (NP
            (NP (JJ appropriate) (NN RT-PCR) (NNS markers))
            (PP (IN for)
              (NP
                (NP (NN use))
                (PP (IN in)
                  (NP
                    (NP (DT a) (NN marker) (NN panel))
                    (S
                      (VP (TO to)
                        (VP (VB detect)
                          (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells))
                          (PP (IN after)
                            (NP (JJ immunomagnetic) (NN enrichment)))))))))))))
      (. .))))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Reverse) (NN transcriptase-polymerase) (NN chain) (NN reaction))
          (PRN (-LRB- -LRB-)
            (NP (NN RT-PCR))
            (-RRB- -RRB-)))
        (NNS assays))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN developed)
            (PP (IN for)
              (NP
                (NP (DT the) (NN detection))
                (PP (IN of)
                  (NP (JJ disseminated) (NN carcinoma) (NNS cells)))))
            (PP (IN by)
              (S
                (VP (VBG targeting)
                  (NP (NN epithelial)
                    (CC or)
                    (NN tumor) (JJ specific) (NN mRNA))
                  (PP (IN in)
                    (NP
                      (NP (NN bone) (NN marrow))
                      (, ,)
                      (NP (JJ peripheral) (NN blood))
                      (, ,)
                      (CC or)
                      (NP
                        (NP (NN lymph) (NNS nodes))
                        (PRN (-LRB- -LRB-)
                          (VP (VBN reviewed)
                            (PP (IN in)
                              (NP (NN -LSB-1))))
                          (-RRB- -RSB-) (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (NP (NNS limitations))
    (VP (MD may)
      (VP (VB arise)
        (PP (IN from)
          (NP
            (NP
              (NP (JJ deficient) (NN expression))
              (PP (IN in)
                (NP (VBG circulating) (NN tumor) (NNS cells))))
            (CC or)
            (NP
              (NP (JJ low) (NN level) (JJ illegitimate) (NN expression))
              (PP (IN in)
                (NP (JJ haematopoietic) (NNS cells))))))
        (, ,)
        (SBAR (RB particularly) (IN if)
          (S
            (NP (DT a) (JJ nested) (NN PCR) (NN approach))
            (VP (VBZ is)
              (VP (VBN used)
                (NP (NN -LSB-2-5))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD developed)
      (NP
        (NP (DT an) (JJ immunobead-based) (NN technique))
        (PP (IN for)
          (NP
            (NP (DT the) (NN enrichment))
            (PP (IN of)
              (NP (JJ epithelial) (NNS cells)))))
        (S
          (VP (TO to)
            (VP (VB increase)
              (NP
                (NP (DT the) (NN signal))
                (PP (TO to)
                  (NP (NN noise) (NN ratio)))
                (PP (IN for)
                  (NP (NN PCR) (NN based) (NNS protocols)
                    (NP (CD -LSB-6))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBD was)
        (ADVP (RB subsequently))
        (VP (VBN adapted)
          (PP (TO to)
            (NP (NN RT-PCR) (NN methodology) (CD -LSB-7)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN shown)
          (NP
            (NP (JJ immunobead) (NN RT-PCR) (VBZ is))
            (PP (IN of)
              (NP (JJ sufficient) (NN sensitivity))))
          (S
            (VP (TO to)
              (VP (VB identify)
                (NP (CD 1) (NN tumor) (JJ epithelial) (NN cell))
                (PP (IN in)
                  (NP
                    (NP (DT a) (NN background))
                    (PP (IN of)
                      (NP (CD 106) (NN blood) (NNS cells) (CD -LSB-7,8) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ recent) (NN study))
      (VP
        (VP (VBD compared)
          (NP (JJ immunobead) (NN RT-PCR))
          (PP (IN with)
            (NP
              (NP (JJ regular) (NN RT-PCR))
              (VP (VBG using)
                (NP (NN CEA))
                (PP (IN as)
                  (NP
                    (NP (DT the) (NN marker))
                    (PP (IN for)
                      (NP
                        (NP (NN colon) (NN cancer) (NNS cells))
                        (VP (VBN spiked)
                          (PP (IN into)
                            (NP (JJ normal) (NN blood) (NNS samples))))))))))))
        (CC and)
        (VP (VBD confirmed)
          (SBAR (IN that)
            (S
              (NP (DT the) (JJ immunobead) (NN RT-PCR) (NN method))
              (VP (VBZ is)
                (ADJP
                  (ADJP (RBR more) (JJ sensitive))
                  (CC and)
                  (ADJP (JJ specific))
                  (PP (IN than)
                    (NP (DT the) (JJ regular) (NN RT-PCR) (NN method) (CD -LSB-9) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (QP (RB Up) (TO to) (CD 100))
          (JJ peripheral) (NN blood) (NNS leukocytes))
        (PRN (-LRB- -LRB-)
          (NP (NNS PBLs))
          (-RRB- -RRB-)))
      (VP (MD may)
        (VP (VB be)
          (ADVP (RB concurrently))
          (VP (VBN isolated)
            (PP (IN with)
              (NP (DT the) (NN tumor) (NNS cells)))
            (PP (IN during)
              (NP (DT the) (JJ immunobead) (NN method) (NN -LSB-10)))
            (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB previously))
      (VP (VBD had)
        (NP
          (NP (JJ similar) (NNS levels))
          (PP (IN of)
            (NP (NN PBL) (NN contamination))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Now)
        (SBAR (IN that)
          (S
            (NP (PRP we))
            (VP
              (VP (VBP carry)
                (PRT (RP out))
                (NP
                  (NP (NNS incubations))
                  (PP (IN at)
                    (NP (NN 4°C)))))
              (CC and)
              (VP (VBP take)
                (PRT (RP off))
                (NP
                  (NP (DT the) (NN cell) (NNS pellets))
                  (PP (IN from)
                    (NP (DT the) (NNS magnets)))
                  (PP (IN for)
                    (NP (VBG washing)))))))))
      (, ,)
      (NP
        (ADJP (RB considerably) (JJR fewer)
          (PP (IN than)
            (NP (CD 10))))
        (NNS cells))
      (VP (VBP are)
        (VP (VBN isolated)
          (PRN (-LRB- -LRB-)
            (NP (JJ unpublished) (NNS observations))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADVP (RB nevertheless))
        (ADJP (JJ important))
        (S
          (VP (TO to)
            (VP (VB assess)
              (SBAR (IN whether)
                (S
                  (NP
                    (NP (DT this) (JJ small) (NN number))
                    (PP (IN of)
                      (NP (NNS cells))))
                  (VP (MD can)
                    (VP (VB lead)
                      (PP (TO to)
                        (NP (JJ false) (NNS positives)))
                      (PP (JJ due) (TO to)
                        (NP (JJ illegitimate) (NN expression))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT this) (NN paper)))
    (, ,)
    (NP (PRP we))
    (VP (VBP introduce)
      (NP
        (NP (DT a) (JJ new) (NN strategy))
        (PP (IN for)
          (NP
            (NP (DT the) (NN testing))
            (PP (IN of)
              (NP
                (NP (NN RT-PCR) (NNS assays))
                (VP (VBG using)
                  (NP
                    (NP (DT a) (NN method))
                    (SBAR
                      (WHPP (IN in)
                        (WHNP (WDT which)))
                      (S
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))
                        (VP (VBZ is)
                          (VP (VBN mixed)
                            (PP (IN with)
                              (NP
                                (NP (CD 100) (NNS PBMNCs))
                                (ADJP (JJ prior)
                                  (PP (TO to)
                                    (NP (NN RT-PCR) (NN analysis))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD 100) (NNS PBMNCs))
        (PP (IN without)
          (NP (VBN added) (NN tumor) (NNS cells))))
      (VP (VBP are)
        (VP (VBN used)
          (PP (IN as)
            (NP (NN specificity) (NNS controls))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN method))
      (VP (VBZ has)
        (VP (VBN allowed)
          (NP
            (NP (DT the) (NN identification))
            (PP (IN of)
              (NP
                (NP (DT a) (NN panel))
                (PP (IN of)
                  (NP
                    (NP (NN RT-PCR) (NNS markers))
                    (PP (IN of)
                      (NP
                        (NP (JJ sufficient) (NN sensitivity))
                        (CC and)
                        (NP (NN specificity))))
                    (PP (IN for)
                      (NP (JJ immunobead) (NN RT-PCR)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN study))
      (VP (VBZ includes)
        (NP
          (NP
            (NP
              (NP (DT an) (NN assessment))
              (PP (IN of)
                (NP
                  (NP (CD 2)
                    (ADJP (RB previously) (VBN untested))
                    (NNS markers))
                  (NP
                    (NP (NN ELF3))
                    (PRN (-LRB- -LRB-)
                      (ADVP (RB also))
                      (VP (VBN known)
                        (PP (IN as)
                          (NP (NN ESX) (-RRB- -RRB-) (CD -LSB-11))))
                      (-RRB- -RSB-))))))
            (CC and)
            (NP (NN EphB4 -LSB-12))
            (-RRB- -RSB-))
          (, ,)
          (CONJP (RB as) (RB well) (IN as))
          (NP
            (NP (DT the)
              (ADJP (RB previously) (VBN studied))
              (NNS markers))
            (NP
              (NP (NN mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-))
              (, ,)
              (NP
                (NP
                  (NP (JJ carcinoembryonic) (NN antigen))
                  (PRN (-LRB- -LRB-)
                    (NP (NN CEA))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (JJ epidermal) (NN growth) (NN factor) (NN receptor))
                  (PRN (-LRB- -LRB-)
                    (NP (NN EGFR))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
                  (PRN (-LRB- -LRB-)
                    (NP (NN EpCAM))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP
                    (NP (NN mammaglobin) (CD 1))
                    (PRN (-LRB- -LRB-)
                      (NP (NN MGB1))
                      (-RRB- -RRB-)))
                  (NNS markers))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whether)
        (S
          (NP (DT a) (NN RT-PCR))
          (VP (VBZ is)
            (ADJP (JJ useful)))))
      (VP (VBZ depends)
        (PP
          (CONJP (RB not) (RB only))
          (PP (IN on)
            (NP
              (NP (DT the) (NN marker))
              (VP (VBN used))))
          (CONJP (CC but)
            (RB also))
          (PP (IN on)
            (NP
              (NP (DT the) (NN assay) (NN conditions))
              (PP (IN for)
                (NP (DT that) (NN marker))))))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ useful) (NN marker))
      (VP (MD will)
        (VP (VB be)
          (ADJP (CC both)
            (ADJP (JJ sensitive) (RB enough)
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP
                      (NP (NN detection))
                      (PP (IN of)
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))))))))
            (CC and)
            (ADJP (JJ specific)))
          (S
            (ADVP (RB enough))
            (VP (TO to)
              (ADVP (RB not))
              (VP (VB be)
                (VP (VBN amplified)
                  (PP (IN from)
                    (NP (NNS PBLs))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (SBAR (IN as)
        (S
          (NP (JJ immunomagnetic) (NN cell) (NNS isolates))
          (VP (VBP have)
            (NP
              (NP
                (ADJP (RB very) (JJ low))
                (NN contamination))
              (PP (IN by)
                (NP (NNS PBLs)))))))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (ADJP (JJ desirable))
        (S
          (VP (TO to)
            (VP (VB check)
              (NP
                (NP (DT the) (NN possibility))
                (PP (IN of)
                  (NP
                    (NP (JJ illegitimate) (NN expression))
                    (PP (IN in)
                      (NP
                        (NP (DT the)
                          (ADJP (RB very) (JJ low))
                          (NN number))
                        (PP (IN of)
                          (NP
                            (NP (NNS PBLs))
                            (SBAR
                              (WHNP (WDT that))
                              (S
                                (VP (VBP are)
                                  (VP (VBN retained)
                                    (PP (IN after)
                                      (NP (DT an) (JJ immunobead) (NN harvest)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB test)
          (NP
            (NP (CC both)
              (NP (NN specificity))
              (CC and)
              (NP (NN sensitivity)))
            (PP (IN of)
              (NP (PRP$ our) (VBN chosen) (NNS markers)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD developed)
      (NP
        (NP (DT an) (NN assay))
        (SBAR
          (WHPP (IN in)
            (WHNP (WDT which)))
          (S
            (NP (DT a) (JJ single) (NN tumor) (NN cell))
            (VP (VBZ is)
              (VP (VBN deposited)
                (PP (IN into)
                  (NP
                    (NP (DT a) (JJ microcentrifuge) (NN tube))
                    (VP (VBG containing)
                      (NP (CD 100) (JJ normal) (NNS PBMNCs)))))))))))
    (. .)))

(
  (S
    (S
      (NP (CD 100) (NNS PBMNCs))
      (VP (VBD were)
        (VP (VBN chosen)
          (SBAR (IN as)
            (S
              (NP (PRP we))
              (VP (VBP believe)
                (SBAR (IN that)
                  (S
                    (NP (DT this) (NN number))
                    (VP (VBZ covers)
                      (NP
                        (NP (DT the) (JJ maximum) (NN amount))
                        (PP (IN of)
                          (NP (NN PBMNC) (NN contamination))))
                      (SBAR (IN that)
                        (S
                          (NP
                            (NP (PRP we))
                            (CC or)
                            (NP (NNS others)))
                          (VP (VBP are)
                            (ADJP (JJ likely)
                              (PP (TO to)
                                (NP (NN encounter))))))))))))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (S
      (NP (JJ Peripheral) (NN blood))
      (VP (VBD was)
        (VP (VBN collected)
          (PP (IN from)
            (NP
              (NP (NNS patients))
              (PP (IN with)
                (NP (NN polycythemia) (NN vera)))
              (SBAR
                (WHNP (WP who))
                (S
                  (VP (VBD presented)
                    (PP (IN for)
                      (NP (NN treatment)))
                    (PP (IN at)
                      (NP
                        (NP (NNP The) (NNP Queen) (NNP Elizabeth) (NNP Hospital))
                        (, ,)
                        (NP (NN Adelaide))
                        (, ,)
                        (NP (NNP Australia))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (VBN Informed) (NN consent))
          (VP (VBD was)
            (VP (VBN obtained)
              (PP (IN in)
                (NP (DT all) (NNS cases))))))
        (CC and)
        (NP (NN ethics) (NN approval)))
      (VP (VBD was)
        (VP (VBN obtained)
          (PP (IN from)
            (NP
              (NP (DT The) (NNP Queen) (NNP Elizabeth) (NNP Hospital) (NNP Ethics))
              (PP (IN of)
                (NP (JJ Human) (NN Research) (NN Committee))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Mononuclear) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN collected)
            (PP (IN by)
              (NP (NN centrifugation)))
            (PP (IN through)
              (NP (DT a) (NN Ficoll) (NN gradient))))
          (, ,)
          (VP (VBN washed)
            (PP (IN with)
              (NP
                (NP (JJ phosphate-buffered) (NN saline))
                (PRN (-LRB- -LRB-)
                  (NP (NN PBS))
                  (-RRB- -RRB-)))))
          (CC and)
          (VP (VBN counted)
            (S
              (VP (VBG using)
                (NP (DT a) (NN haemocytometer))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (DT the) (NN course))
          (PP (IN of)
            (NP (DT this) (NN investigation)))))
      (, ,)
      (NP
        (NP (NNS PBMNCs))
        (PP (IN from)
          (NP (CD eight) (JJ different) (NNS patients))))
      (VP (VBD were)
        (VP (VBN used))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN breast) (NN cancer) (NN cell) (NNS lines))
        (NP
          (NP (NN MDA-MB-453))
          (, ,)
          (NP
            (ADJP (JJ T47-D)))
          (, ,)
          (NP (NN MDA-MB-468))
          (, ,)
          (NP (NN MCF-7))
          (, ,)))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP
              (NP
                (NP
                  (NP (NN DMEM))
                  (, ,)
                  (NP (NN pH) (CD 7.4)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Invitrogen) (, ,) (NNP Carlsbad))
                  (, ,)
                  (NP (NN CA))
                  (-RRB- -RRB-)))
              (VP (VBN supplemented)
                (PP (IN with)
                  (NP
                    (NP
                      (NP
                        (ADJP (CD 100) (NN U/ml))
                        (NN penicillin))
                      (, ,)
                      (NP
                        (ADJP (CD 100) (NN μg/ml))
                        (NN streptomycin))
                      (, ,)
                      (NP
                        (ADJP (CD 160) (NN μg/ml))
                        (NN L-glutamine))
                      (CC and)
                      (NP
                        (ADJP (CD 10) (NN %))
                        (NP
                          (NP (JJ heat-inactivated) (JJ fetal) (JJ bovine) (NN serum))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP JRH) (NNP Biosciences) (, ,) (NNP Lenexa))
                            (, ,)
                            (NP (NN KS))
                            (-RRB- -RRB-)))))
                    (PP (IN in)
                      (NP
                        (NP (CD 75) (NN cm2) (JJ vented) (NN tissue) (NN culture) (NNS flasks))
                        (PP (IN at)
                          (NP
                            (NP (NN 37°C))
                            (PP (IN in)
                              (NP (DT a)
                                (ADJP (CD 5) (NN %))
                                (NN CO2) (NN environment)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Log) (NN phase) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN collected)
            (PP (IN at)
              (NP
                (ADJP
                  (QP (JJR less) (IN than) (CD 90))
                  (NN %))
                (NN confluency)))
            (PP (IN by)
              (NP
                (NP
                  (NP (NN trypsin))
                  (NN digestion))
                (CC and)
                (NP (NN centrifugation))))
            (PP (IN for)
              (NP (CD 5) (NN min)))
            (PP (IN at)
              (NP (CD 1000) (NN rpm))))
          (, ,)
          (VP (VBN resuspended)
            (PP (IN in)
              (NP
                (NP (NN phosphate) (JJ buffered) (NN saline))
                (PRN (-LRB- -LRB-)
                  (NP (NN PBS))
                  (-RRB- -RRB-)))))
          (CC and)
          (VP (VBN counted)
            (S
              (VP (VBG using)
                (NP (DT a) (NN haemocytometer))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN cell) (NNS lines))
      (VP (VBD were)
        (VP (VBN purchased)
          (PP (IN from)
            (NP
              (NP (DT the)
                (NP (NNP American))
                (NN Type) (NN Culture) (NN Collection))
              (PRN (-LRB- -LRB-)
                (NP (NNP ATCC) (, ,) (NNP Rockville) (, ,) (NNP MD))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ dilute) (NN suspension))
        (PP (IN of)
          (NP (DT a) (NN cell) (NN line))))
      (VP (VBD was)
        (VP (VBN prepared)
          (PP (IN in)
            (NP
              (NP
                (NP (NN calcium))
                (CC and)
                (NP (NN magnesium)))
              (JJ free) (NN Dulbecco) (POS 's) (NNS PBS))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Single) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN visualised)
            (S
              (VP (VBG using)
                (NP (DT an) (VBN inverted) (NN phase) (NN microscope)))))
          (CC and)
          (VP (VBN selected)
            (PP (IN by)
              (S
                (VP (VBG using)
                  (NP
                    (NP (DT a) (NN micropipette))
                    (S
                      (VP (TO to)
                        (VP (VB draw)
                          (PRT (RP up))
                          (NP
                            (NP (DT the) (NN cell))
                            (PP (IN in)
                              (NP (DT a) (CD 1) (NN μl) (NN volume)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN cell))
      (VP (VBD was)
        (VP (VBN deposited)
          (PP (IN into)
            (NP
              (NP (DT a)
                (ADJP (CD 0.5) (NN ml))
                (NN microcentrifuge) (NN tube))
              (VP (VBG containing)
                (NP
                  (NP (CD 100) (JJ peripheral) (NN blood) (JJ mononuclear) (NNS cells))
                  (PP (IN in)
                    (NP
                      (NP (CD 1) (NN μl))
                      (PP (IN of)
                        (NP
                          (NP
                            (NP (NN calcium))
                            (CC and)
                            (NP (NN magnesium)))
                          (JJ free) (NN Dulbecco) (POS 's) (NNS PBS))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Aliquots))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD contained)
              (NP (CD 100) (JJ mononuclear) (NNS cells))))))
      (ADVP (RB only))
      (VP (VBD were)
        (VP (VBN included)
          (PP (IN as)
            (NP
              (NP (NNS controls))
              (PP (IN for)
                (NP
                  (NP (DT the) (NN specificity))
                  (PP (IN of)
                    (NP (DT the) (NN RT-PCR))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN cell) (NN mixture))
      (VP (VBD was)
        (VP (VBN lysed)
          (PP (IN in)
            (NP
              (NP (DT a)
                (ADJP (CD 15) (NN μl))
                (NN volume))
              (PP (IN of)
                (NP
                  (NP (NN solution))
                  (VP (VBG containing)
                    (NP
                      (NP
                        (NP
                          (ADJP (CD 0.3) (NN %))
                          (NN v/v) (NN Nonidet) (NN P-40) (NN detergent))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Sigma))
                          (-RRB- -RRB-)))
                      (, ,)
                      (NP
                        (NP
                          (ADJP (CD 500) (NN ng))
                          (JJ random) (NNS hexamers))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Pharmacia) (, ,) (NNP Uppsala) (, ,) (NNP Sweden))
                          (-RRB- -RRB-)))
                      (, ,)
                      (NP
                        (NP
                          (NP (CD 20) (NN U))
                          (PP (IN of)
                            (NP (NN RNasin))))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP Promega) (, ,) (NNP Madison) (, ,) (NNP WI))
                          (-RRB- -RRB-)))
                      (CC and)
                      (NP
                        (ADJP (CD 10) (NN mM))
                        (NN DTT)))))))))))
    (. .)))

(
  (S
    (PP (VBG Following)
      (NP
        (NP (NN 70°C) (NN denaturation))
        (PP (IN for)
          (NP (CD 3) (NNS minutes)))))
    (, ,)
    (NP (JJ reverse) (NN transcription))
    (VP (VBD was)
      (VP (VBN initiated)
        (PP (IN by)
          (NP
            (NP (DT the) (NN addition))
            (PP (IN of)
              (NP
                (NP
                  (NP (JJ 5×) (JJ First) (NN Strand) (NN Buffer))
                  (, ,)
                  (NP
                    (NP (CD 200) (NN U))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN Superscript) (CD II))
                          (PRN (-LRB- -LRB-)
                            (NP (NNP Invitrogen))
                            (-RRB- -RRB-)))
                        (, ,)
                        (NP
                          (NP (CD 0.5) (NN mM))
                          (PP (IN of)
                            (NP
                              (NP (DT each) (NN deoxynucleotide) (NN triphosphate))
                              (PRN (-LRB- -LRB-)
                                (NP (NNP Roche) (, ,) (NNP Mannheim) (, ,) (NNP Germany))
                                (-RRB- -RRB-))))))))
                  (, ,))
                (PP (IN with)
                  (NP
                    (NP (JJ Ultra-pure) (NN water))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Fisher) (NNP Biotech) (, ,) (NNP Perth) (, ,) (NNP Australia))
                      (-RRB- -RRB-))))))
            (PP (TO to)
              (NP
                (NP (DT a) (JJ final) (NN volume))
                (PP (IN of)
                  (NP (CD 30) (NN μl)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NN reaction))
        (VP (VBD was)
          (VP (VBN incubated)
            (PP (IN at)
              (NP (NN 42°C)))
            (PP (IN for)
              (NP (CD 50) (NNS minutes))))))
      (, ,)
      (CC and)
      (S
        (NP (RB then) (DT the) (JJ reverse) (NN transcriptase))
        (VP (VBD was)
          (VP (VBN inactivated)
            (PP (IN at)
              (NP (NN 70°C)))
            (PP (IN for)
              (NP (CD 10) (NNS minutes)))))))
    (. .)))

(
  (S
    (PP (IN After)
      (NP (JJ reverse) (NN transcription)))
    (, ,)
    (NP
      (NP (CD 4) (NN μl))
      (PP (IN of)
        (NP (NN cDNA))))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN as)
          (NP
            (NP (DT the) (NN template))
            (PP (IN in)
              (NP
                (NP (DT a) (JJ single) (NN round))
                (PP (IN of)
                  (NP
                    (NP (NN PCR) (NN amplification))
                    (PP (IN with)
                      (NP
                        (NP
                          (NP
                            (NP (CD 200) (NN nM))
                            (PP (IN of)
                              (NP (DT each) (NN gene) (JJ specific) (NN primer) (NN pair))))
                          (PRN (-LRB- -LRB-)
                            (NP (NN Table) (CD 1))
                            (-RRB- -RRB-)))
                        (, ,)
                        (NP
                          (NP
                            (NP (CD 1) (NN U))
                            (PP (IN of)
                              (NP (JJ Hot) (NN Star) (NN Taq))))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP (NN Qiagen))
                              (, ,)
                              (NP (NN Valencia))
                              (, ,)
                              (NP (NN CA)))
                            (-RRB- -RRB-)))
                        (, ,)
                        (NP
                          (ADJP (CD 2.5) (NN mM))
                          (NN MgCl2))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (CD 200) (NN μM))
                          (PP (IN of)
                            (NP (DT each) (NN deoxynucleotide) (NN triphosphate))))))))))))
        (, ,)
        (PP (IN in)
          (NP (DT the) (VBN supplied) (NN PCR) (NN buffer)))))
    (. .)))

(
  (S
    (NP (NN Cycling) (NNS conditions))
    (VP (VBD included)
      (NP (DT an) (JJ initial) (NN denaturation) (NN step))
      (PP (IN at)
        (NP
          (NP (NN 95°C))
          (PP (IN for)
            (NP (CD 15) (NNS minutes)))))
      (, ,)
      (ADVP (RB then))
      (NP
        (NP
          (NP (CD 1) (NN minute))
          (PP (IN at)
            (NP
              (NP (DT each))
              (PP (IN of)
                (NP
                  (NP (NN 94°C))
                  (, ,)
                  (NP (NN 66–68°C))
                  (CC and)
                  (NP (NN 72°C))))))
          (PP (IN for)
            (NP (CD 45–55) (NNS cycles))))
        (CC and)
        (NP
          (NP (DT a) (JJ final) (NN extension))
          (PP (IN of)
            (NP (CD 7) (NNS minutes)))
          (PP (IN at)
            (NP (NN 72°C))))))
    (. .)))

(
  (S
    (S
      (NP (NN Amplification) (NNS products))
      (VP (VBD were)
        (VP (VBN visualised)
          (PP (IN by)
            (NP
              (NP (NN ethidium) (NN bromide))
              (NN staining)))
          (PP (VBG following)
            (NP (NN separation)))
          (PP (IN by)
            (NP (NN electrophoresis)))
          (PP (IN through)
            (NP (NN agarose) (NNS gels))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT each) (NN case)))
    (NP
      (NP (DT an) (NN RT) (JJ negative) (NN control))
      (, ,)
      (VP (VBN made)
        (PRT (RP up))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS components))
            (PP (IN of)
              (NP
                (NP (DT the) (NN RT) (NN reaction) (NN mixture))
                (PP (IN with)
                  (CC or)
                  (PP (IN without)
                    (NP (NN lysis) (NN mix)))
                  (, ,)
                  (CC and)
                  (PP (IN without)
                    (NP
                      (NP (DT the) (NN addition))
                      (PP (IN of)
                        (NP (NN RNA)))))))))))
      (, ,))
    (VP (VBD was)
      (VP (VBN used)
        (PP (IN as)
          (NP (DT the) (NN template)))
        (PP (IN in)
          (NP (DT the) (NN PCR) (NN reaction)))
        (PRN (-LRB- -LRB-)
          (S
            (S
              (NP (DT no) (NN cDNA))
              (VP (VBN made)))
            (CC and)
            (S
              (ADVP (RB therefore))
              (NP (DT no) (NN amplification))
              (VP (VBN expected))))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN PCR) (JJ negative) (NN control))
      (VP
        (VP (VBZ contains)
          (NP
            (NP (DT the) (NNS reagents))
            (PP (IN of)
              (NP (DT the) (NN PCR) (NN reaction)))))
        (CC but)
        (VP (VBZ lacks)
          (NP (NN template)))))
    (. .)))

(
  (S
    (S
      (NP (NN Cell) (NN line) (NN cDNA))
      (VP (VBD was)
        (VP (VBN included)
          (PP (IN as)
            (NP
              (NP (DT a) (JJ positive) (NN control))
              (PP (IN for)
                (NP (DT the) (NN PCR) (NN reaction))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Genomic) (NN DNA))
        (PRN (-LRB- -LRB-)
          (NP (CD 100) (NN ng))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB confirm)
                (SBAR (IN that)
                  (S
                    (NP
                      (NP (DT a) (NN product))
                      (PP (IN of)
                        (NP (JJ equal) (NN size)))
                      (PP (TO to)
                        (NP (DT the) (NN cDNA) (NN product))))
                    (VP (MD would) (RB not)
                      (VP (VB be)
                        (VP (VBN amplified)
                          (PP (IN from)
                            (NP (DT the) (NN DNA)))
                          (PP (IN in)
                            (NP (DT the) (NN cell) (NN lysate))))))))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN expression))
        (PP (IN of)
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP (DT the) (NN RT-PCR) (NNS markers))))))
      (VP (VBD was)
        (VP (VBN assessed)
          (PP (IN for)
            (NP
              (NP (PRP$ its) (NN suitability))
              (PP (IN as)
                (NP (DT a) (NN breast) (NN cancer) (NN marker))))))))
    (. .)))

(
  (S
    (S
      (NP (NN RNA))
      (VP (VBD was)
        (VP (VBN extracted)
          (PP (IN from)
            (NP (CD seven) (NN breast) (NN cancer) (NN cell) (NNS lines)))
          (, ,)
          (S
            (NP (NN reverse))
            (VP (VBN transcribed)
              (PP (IN into)
                (NP (NN cDNA))))))
        (ADVP (RB then))
        (VP (VBN amplified)
          (S
            (VP (VBG using)
              (NP
                (NP (NNS primers))
                (ADJP (JJ specific)
                  (PP (IN for)
                    (NP
                      (NP (DT the) (JJ different) (NNS markers))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Table) (CD 1))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Transcripts))
        (VP (VBG corresponding)
          (PP (TO to)
            (NP (NN EpCAM)))))
      (VP (VBD were)
        (VP (VBN amplified)
          (PP (IN from)
            (NP
              (NP (DT all))
              (PP (IN of)
                (NP
                  (NP (DT the) (NN cell) (NNS lines))
                  (VP (VBN tested))))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Fig.) (LS 1.))
              (, ,)
              (NP (NN panel) (CD 1)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (NP (DT This))
    (VP
      (VP (VBZ validates)
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP
              (NP (NNS antibodies))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP recognise)
                    (NP
                      (NP (NNS epitopes))
                      (PP (IN of)
                        (NP (DT this) (NN protein))))))))))
        (PP (IN as)
          (NP
            (NP (DT the) (JJ immunobead) (VB label))
            (PRN
              (PP (IN for)
                (NP
                  (NP (JJ magnetic) (NN isolation))
                  (PP (IN of)
                    (NP (DT the) (NN breast) (NN carcinoma) (NNS cells)))))
              (NP (CD -LSB-6))
              (-RRB- -RSB-)))))
      (CC and)
      (VP (VBZ confirms)
        (NP
          (NP (JJR earlier) (NNS results))
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBD showed)
                (NP (JJ uniform) (JJ bright) (NN fluorescence))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (NN breast) (NN cancer) (NN cell) (NNS lines))
                      (CC and)
                      (NP (NNS biopsies)))
                    (VP (VBN stained)
                      (PP (IN with)
                        (NP
                          (NP
                            (NP (CD one))
                            (PP (IN of)
                              (NP (DT these) (NNS antibodies))))
                          (, ,)
                          (NP (NN Ber-Ep4) (CD -LSB-7) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN ELF3))
        (, ,)
        (NP (NN EphB4))
        (CC and)
        (NP (NN MUC1)))
      (VP (VBD were)
        (VP (VBN amplified)
          (PP (IN in)
            (NP (DT all) (NN cell) (NNS lines)))
          (PP (IN at)
            (NP
              (ADJP (RB consistently) (JJ high))
              (NNS levels)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Fig.) (CD 1))
              (, ,)
              (NP (NNS panels)
                (QP (CD 2) (, ,) (CD 3)
                  (CC and)
                  (CD 4))))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN EGFR) (NN expression))
      (VP (VBD was)
        (ADVP (RB also))
        (ADJP (RB easily) (JJ detectable))
        (PRN (-LRB- -LRB-)
          (NP (NNP Fig.) (CD 1))
          (, ,)
          (NP (NN panel) (CD 5))
          (-RRB- -RRB-))
        (SBAR (RB even) (IN though)
          (S
            (NP (JJ several) (NNS reports))
            (VP (VBP have)
              (VP (VBN suggested)
                (S
                  (NP (PRP it))
                  (VP
                    (VP (VBZ is)
                      (VP (VBN expressed)
                        (PP (IN at)
                          (NP (JJ low) (NNS levels)))
                        (PP (IN in)
                          (NP
                            (NP (NN MCF-7))
                            (CC and)
                            (NP
                              (ADJP (JJ T47-D)))))))
                    (CC and)
                    (VP (VBZ is) (RB not)
                      (VP (VBN expressed)
                        (PP (IN in)
                          (NP (NN MDA-MB-453) (CD -LSB-13,14) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN MGB1) (NNS transcripts))
        (VP (VBD were)
          (VP (VBN amplified)
            (PP (IN from)
              (NP
                (NP (DT all) (NN cell) (NNS lines))
                (PP (IN except) (IN for)
                  (NP (NN MCF-7)))))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Fig.) (CD 1))
                (, ,)
                (NP (NN panel) (CD 2)))
              (-RRB- -RRB-)))))
      (CC and)
      (S
        (NP (NN CEA))
        (VP (VBD was)
          (VP (VBN amplified)
            (PP (IN from)
              (NP (DT all) (NN cell) (NNS lines)))
            (PP (IN except)
              (NP (NN PMC42)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Fig.))
                (NP (CD 1) (NN panel) (CD 6)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NNS Tubes))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBD contained)
                (NP (CD 100) (NN PBMNCs))))))
        (CC and)
        (NP (CD one) (NN tumor) (NN cell)))
      (VP (VBD were)
        (VP (VBN used)
          (S
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (DT the) (NN sensitivity))
                  (PP (IN of)
                    (NP (DT each) (NN RT-PCR) (NN marker))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (JJS Most))
          (PP (IN of)
            (NP (DT the) (NN sensitivity) (NNS tests))))
        (VP (VBD were)
          (VP (VBN performed)
            (S
              (VP (VBG using)
                (NP (NN MDA-MB-453) (NNS cells)))))))
      (CC but)
      (S
        (NP (CD four) (JJ different) (NN breast) (NN cancer) (NN cell) (NNS lines))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN included)
              (PP (IN in)
                (NP
                  (NP (DT this) (NN part))
                  (PP (IN of)
                    (NP (DT the) (NN study)))))
              (, ,)
              (S
                (NP
                  (NP
                    (NP (CD two))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP are)
                          (ADJP
                            (ADJP (NN ER) (JJ negative))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN MDA-MB-453))
                                (, ,)
                                (CC and)
                                (NP (NN MDA-MB-468)))
                              (-RRB- -RRB-)))))))
                  (CC and)
                  (NP
                    (NP (CD two))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP are)
                          (ADJP
                            (ADJP (NN ER) (JJ positive))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN MCF-7))
                                (CC and)
                                (NP (JJ T47-D)))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (VP (VBG Analysing)
        (NP
          (NP (DT the) (NNS samples))
          (SBAR
            (WHPP (TO to)
              (WHNP (WDT which)))
            (S
              (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell))
              (VP (VBD had)
                (VP (VBN been)
                  (VP (VBN added)
                    (PP (TO to)
                      (NP (CD 100) (NN PBMNC)))))))))))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (PRP we))
          (VP (MD can)
            (VP (VB detect)
              (NP (DT the) (NN tumor) (NN cell))
              (ADVP (RBS most) (RB often))
              (PP (IN with)
                (NP
                  (NP
                    (NP (NN ELF3))
                    (PRN (-LRB- -LRB-)
                      (NP (NN 40/43) (NN –) (CD 93) (NN %))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP
                      (NP (NN EpCAM))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 36/40) (NN –) (CD 89) (NN %))
                        (-RRB- -RRB-)))
                    (PRN (-LRB- -LRB-)
                      (NP (NNS Figures)
                        (NP (CD 2)
                          (CC and)
                          (CD 3)))
                      (, ,)
                      (NP (NNS tables) (CD 2)
                        (CC and)
                        (CD 3))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN EphB4) (JJ specific) (NN amplification))
      (VP (VBD detected)
        (NP
          (NP (CD 31/40))
          (PRN (-LRB- -LRB-)
            (NP (CD 77.5) (NN %))
            (-RRB- -RRB-)))))
    (. ,)))

(
  (S
    (S
      (NP (NN MUC1))
      (NP
        (NP
          (NP (CD 10/20))
          (PRN (-LRB- -LRB-)
            (NP (CD 67) (NN %))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN CEA) (NN 9/20))
          (PRN (-LRB- -LRB-)
            (NP (CD 45) (NN %))
            (-RRB- -RRB-)))
        (, ,)
        (NP
          (NP (NN EGFR) (NN 19/43))
          (PRN (-LRB- -LRB-)
            (NP (CD 44) (NN %))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP (NN MGB1) (NN 9/35))
          (PRN (-LRB- -LRB-)
            (NP (CD 26) (NN %))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Tubes))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD contained)
              (NP (CD 100) (NN PBMNCs))
              (ADVP (RB only))))))
      (VP (VBD were)
        (VP (VBN included)
          (S
            (VP (TO to)
              (VP (VB determine)
                (NP
                  (NP (NN specificity))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Table) (CD 2))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (PP (IN After)
      (S
        (VP (VBG combining)
          (NP
            (NP (DT the) (NNS data))
            (VP (VBN obtained)
              (PP (IN from)
                (NP
                  (NP
                    (NP (JJ several) (JJ different) (NNS experiments))
                    (CC and)
                    (NP (JJ several) (JJ different) (JJ normal) (NNS individuals)))
                  (PP (IN in)
                    (NP
                      (NP (NNS reactions))
                      (VP (VBG using)
                        (NP
                          (NP (DT the) (JJ appropriate) (NN number))
                          (PP (IN of)
                            (NP (NN amplification) (NNS cycles))))))))))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (NP
        (NP (DT no) (NN expression))
        (PP (IN of)
          (NP
            (NP
              (NP (NN EGFR) (-LRB- -LRB-) (CD 0/27) (-RRB- -RRB-))
              (, ,)
              (NP
                (NP (NN MGB1) (-LRB- -LRB-) (CD 0/24) (-RRB- -RRB-))
                (, ,)
                (NP (NN EphB4) (-LRB- -LRB-) (CD 0/21) (-RRB- -RRB-))
                (, ,)
                (NP (NN EpCAM) (-LRB- -LRB-) (CD 0/21) (-RRB- -RRB-))
                (CC or)
                (NP (NN CEA) (-LRB- -LRB-) (CD 0/18) (-RRB- -RRB-)))
              (, ,))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNS Figures)
                  (QP (CD 2)
                    (CC and)
                    (CD 3)))
                (, ,)
                (NP (NN Table) (CD 2)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Only))
      (NP
        (NP (NN ELF3))
        (CC and)
        (NP (NN MUC1)))
      (VP (VBD gave)
        (NP (JJ positive) (NNS bands))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS results))
      (VP (VBD were)
        (PP (IN for)
          (NP
            (NP (CD 45) (NNS cycles))
            (PP (IN of)
              (NP (NN amplification)))))
        (PP (IN except)
          (PP (IN for)
            (NP
              (NP (NN CEA))
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD was)
                    (NP (NN run))
                    (PP (IN for)
                      (NP (CD 55) (NNS cycles)))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB also))
      (VP (VBD examined)
        (NP
          (NP
            (NP (NN ELF3))
            (, ,)
            (NP (NN EphB4))
            (CC and)
            (NP (NN MUC1)))
          (PP (IN at)
            (NP (CD 55) (NNS cycles)))
          (PP (IN in)
            (NP
              (NP (DT a) (JJ small) (NN number))
              (PP (IN of)
                (NP (NNS experiments))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD amplified)
      (NP
        (NP (NNS transcripts))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBD corresponded)
              (PP (TO to)
                (NP
                  (NP
                    (NP (NN ELF3))
                    (PRN (-LRB- -LRB-)
                      (NP (NN 1/6))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (NN EphB4))
                    (PRN (-LRB- -LRB-)
                      (NP (NN 3/12))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP
                      (NP (NN MUC1))
                      (PRN (-LRB- -LRB-)
                        (NP (NN 3/12))
                        (-RRB- -RRB-)))
                    (PP (IN in)
                      (NP
                        (NP (DT some))
                        (PP (IN of)
                          (NP (DT the) (NN PBMNC) (NN control) (NNS tubes)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The)
        (NP
          (NP (NN ELF3))
          (CC and)
          (NP (NN EphB4)))
        (NNS bands))
      (VP
        (VP (VBD were)
          (ADJP (JJ visible))
          (PP (VBG following)
            (NP
              (NP (NN ethidium) (NN bromide))
              (NN staining))))
        (CC but)
        (VP (VBD were)
          (ADJP (RBR less) (JJ intense))
          (PP
            (PP (IN than)
              (NP
                (NP (DT the) (NN band))
                (VP (VBN amplified)
                  (PP (IN after)
                    (NP
                      (NP (DT the) (NN addition))
                      (PP (IN of)
                        (NP (DT a) (JJ single) (NN tumor) (NN cell))))))))
            (CC and)
            (PP (IN in)
              (NP
                (NP (DT no) (NNS cases))
                (VP (VBD were)
                  (NP
                    (NP (DT all) (CD three))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN PBMNC) (NNS controls))
                        (ADJP (JJ positive)
                          (PP (IN in)
                            (NP (DT the) (JJ same) (NN experiment))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VB assume)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN ELF3) (NN band))
            (VP (VBZ is)
              (NP
                (NP (DT a) (NN result))
                (PP (IN of)
                  (NP
                    (NP (NN amplification))
                    (PP (IN of)
                      (NP (JJ illegitimate) (NNS transcripts)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN band))
      (VP (VBD was)
        (VP (VBN eliminated)
          (SBAR
            (WHADVP (WRB when))
            (S
              (S
                (NP
                  (NP
                    (QP (RB only) (CD 35))
                    (NNS cycles))
                  (PP (IN of)
                    (NP
                      (NP (NN amplification))
                      (PRN (-LRB- -LRB-)
                        (NP (NN 0/15))
                        (-RRB- -RRB-)))))
                (VP (VBD were)
                  (VP (VBN performed))))
              (CC but)
              (S
                (SBAR (IN because)
                  (S
                    (NP
                      (NP (RB only) (DT a) (JJ small) (NN amount))
                      (PP (IN of)
                        (NP (NN product))))
                    (VP (VBD was)
                      (VP (VBN amplified)
                        (PP (IN after)
                          (NP
                            (QP (CD 45)
                              (CC or)
                              (CD 55))
                            (NNS cycles)))
                        (PP (IN in)
                          (NP (DT these) (NNS controls)))))))
                (NP (PRP we))
                (VP (MD could)
                  (VP (VB distinguish)
                    (NP
                      (NP (NNS samples))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (VBD contained)
                            (NP
                              (NP (NN tumor) (NNS cells))
                              (CC and)
                              (NP
                                (NP (DT those))
                                (SBAR
                                  (WHNP (WDT that))
                                  (S
                                    (VP (VBD did)
                                      (ADVP (RB not))
                                      (PP (IN through)
                                        (NP
                                          (NP (NN comparison))
                                          (PP (IN of)
                                            (NP
                                              (NP (DT the) (NN intensity))
                                              (PP (IN of)
                                                (NP (NNS bands))))))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Analysing)
          (NP
            (NP (DT the) (NNS samples))
            (SBAR
              (WHPP (TO to)
                (WHNP (WDT which)))
              (S
                (NP (DT a) (JJ single) (NN breast) (NN cancer) (NN cell))
                (VP (VBD had)
                  (VP (VBN been)
                    (VP (VBN added)
                      (PP (TO to)
                        (NP (CD 100) (NN PBMNC)))))))))))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (PRP we))
            (VP (MD could)
              (ADVP (RB still))
              (VP (VB detect)
                (NP (DT the) (NN tumor) (NN cell))
                (ADVP (RBS most) (RB often))
                (PP (IN with)
                  (NP
                    (NP (NN ELF3))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 15/16) (NN –) (CD 94) (NN %))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Tests))
        (VP (VBG using)
          (NP (JJ single) (NN tumour) (NNS cells))
          (PP (IN in)
            (NP (DT a) (CD 100) (NN PBMNC) (NN background)))))
      (VP (VBD detected)
        (NP
          (NP
            (NP (CD 15/16))
            (PRN (-LRB- -LRB-)
              (NP (CD 94) (NN %))
              (-RRB- -RRB-)))
          (PP (IN of)
            (NP (NN tumour) (NNS cells))))
        (PP (IN after)
          (NP (CD 35) (NNS cycles)))))
    (. .)))

(
  (S
    (S
      (PP (IN Unlike)
        (NP (NN ELF3)))
      (, ,)
      (NP (DT the) (NN MUC1) (NN PBMNC) (NN band))
      (VP (VBD was)
        (PP (IN of)
          (NP
            (NP (JJ comparable) (NN intensity))
            (PP (TO to)
              (NP
                (NP (DT those))
                (VP (VBN achieved)
                  (PP (IN after)
                    (NP (NN tumor) (NN cell) (NN addition))))))))
        (S
          (VP (VBG making)
            (S
              (NP (PRP it))
              (ADJP (JJ impossible)
                (S
                  (VP (TO to)
                    (VP (VB distinguish)
                      (NP
                        (NP (NNS samples))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBP contain)
                              (NP (NN tumor) (NNS cells))))))
                      (PP (IN from)
                        (NP
                          (NP (DT those))
                          (SBAR
                            (WHNP (WDT that))
                            (S
                              (VP (VBP do) (RB n't)
                                (PRN (-LRB- -LRB-)
                                  (NP (NN Figure) (CD 2))
                                  (-RRB- -RRB-))))))))))))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN development))
        (PP (IN of)
          (NP
            (NP (VBN optimized) (NNS methods))
            (PP (IN for)
              (S
                (VP (VBG detecting)
                  (NP (NN tumor) (NNS cells))
                  (PP (IN in)
                    (NP
                      (NP (DT the)
                        (NP (JJ peripheral) (NN blood))
                        (CC and)
                        (NP (NN bone) (NN marrow)))
                      (PP (IN of)
                        (NP (NN cancer) (NNS patients)))))))))))
      (VP (MD may)
        (VP (VB enhance)
          (NP (PRP$ our) (NN ability)
            (S
              (VP (TO to)
                (VP (VB identify)
                  (NP (DT those) (NNS patients))
                  (PP (IN in)
                    (NP
                      (NP (NN need))
                      (PP (IN of)
                        (NP (JJ further) (NN therapy))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Nested) (NN RT-PCR))
        (PP (IN of)
          (NP (NNS PBMNCs))))
      (VP (VBZ has)
        (VP (VBN been)
          (NP
            (NP (DT the)
              (ADJP (RBS most) (JJ common))
              (NN method))
            (S
              (VP (TO to)
                (VP (VB detect)
                  (NP (JJ epithelial) (NN –) (JJ specific) (NNS markers)))))))))
    (. .)))

(
  (S
    (PP (IN Due)
      (PP (TO to)
        (NP
          (NP (DT the) (JJ high) (NN level))
          (PP (IN of)
            (NP
              (NP (NN sensitivity))
              (PP (IN of)
                (NP (JJ nested) (NN RT-PCR))))))))
    (, ,)
    (NP
      (NP
        (ADJP (RB even) (JJ low))
        (NNS levels))
      (PP (IN of)
        (NP
          (NP (JJ illegitimate) (NN transcription))
          (PP (IN in)
            (NP (NNS PBMNCs))))))
    (VP (MD can)
      (VP (VB cause)
        (NP (JJ false-positive) (NNS results) (CD -LSB-2-5) (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ Nested) (NN RT-PCR))
        (VP (VBZ is)
          (ADVP (RB also))
          (ADJP (RBR more) (NN time) (JJ consuming))))
      (CC and)
      (S
        (NP (JJ stringent) (NNS procedures))
        (VP (VBP need)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN observed)
                  (SBAR (IN in) (NN order)
                    (S
                      (VP (TO to)
                        (VP (VB minimise)
                          (NP
                            (NP (DT the) (NN risk))
                            (PP (IN of)
                              (NP (JJ false) (NNS positives))))
                          (PP (JJ due) (TO to)
                            (NP (NN PCR) (NN product) (NN cross) (NN contamination))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADVP (RB thus))
        (NP (NN desirable)
          (SBAR (IN that)
            (S
              (NP (DT the) (NN RT-PCR))
              (VP (VBZ is)
                (VP (VBN performed)
                  (PP (IN in)
                    (NP
                      (NP (DT a) (JJ single) (NN round))
                      (S
                        (VP (TO to)
                          (VP (VB avoid)
                            (NP (JJ potential) (NN contamination) (NNS problems))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN use))
        (PP (IN of)
          (NP (JJ immunobead) (NN enrichment)))
        (ADVP
          (ADVP (RB prior))
          (PP (TO to)
            (NP (JJ reverse) (NN transcription)))))
      (VP (VBZ has)
        (VP (VBN allowed)
          (NP
            (NP (DT the) (NN use))
            (PP (IN of)
              (NP
                (NP (DT a) (JJ single) (NN round))
                (PP (IN of)
                  (NP (NN PCR) (NN amplification)))))
            (S
              (VP (TO to)
                (VP (VB screen)
                  (NP (DT a) (JJ whole) (NN blood) (NN sample)))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (PRP$ Our) (JJ original) (NN methodology))
        (VP (VBD used)
          (NP
            (NP
              (NP (NN blotting))
              (CC and)
              (NP (NN detection)))
            (PP (IN with)
              (NP (DT an) (NN oligonucleotide))))
          (S
            (VP (TO to)
              (VP (VB increase)
                (NP (NN sensitivity) (CD -LSB-7) (-RRB- -RSB-)))))))
      (CC but)
      (S
        (NP (DT this))
        (VP (VBZ is)
          (ADVP (RB no) (RBR longer))
          (ADJP (JJ necessary)
            (PP (IN with)
              (NP
                (NP (DT the)
                  (ADJP (RBR more) (JJ efficient))
                  (NN RT-PCR) (NNS assays))
                (VP (VBN presented)
                  (ADVP (RB here))))))
          (, ,)
          (PP (IN in)
            (NP
              (NP (JJ particular))
              (PP (IN because)
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN use))
                    (PP (IN of)
                      (NP (DT a) (JJ hot) (NN start) (NN Taq) (NN polymerase)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB improve)
            (NP (NN RT-PCR) (NN detection))
            (ADVP (RB further)))))
      (, ,)
      (S
        (NP
          (NP (DT the) (NN identification))
          (PP (IN of)
            (NP
              (NP (JJ epithelial)
                (CC or)
                (NN carcinoma) (NN cell) (JJ specific) (NNS markers))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP are)
                    (VP (VBN expressed)
                      (PP (IN at)
                        (NP (DT a) (JJ sufficient) (NN level)
                          (S
                            (VP (TO to)
                              (VP (VB enable)
                                (NP
                                  (NP (NN detection))
                                  (PP (IN of)
                                    (NP (DT a) (JJ single) (NN cell))))
                                (PP (IN after)
                                  (NP
                                    (NP
                                      (QP (RB only) (CD one))
                                      (NN round))
                                    (PP (IN of)
                                      (NP (JJ non-nested) (NN PCR)))))))))))))))))
        (VP (VBP are)
          (VP (VBN needed)))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (DT this) (NN reason)))
      (, ,)
      (NP (PRP we))
      (VP (VBP have)
        (VP (VBN used)
          (NP
            (NP (JJ single) (NN tumor) (NNS cells))
            (PP (IN in)
              (NP
                (NP (DT a) (NN background))
                (PP (IN of)
                  (NP (CD 100) (NNS PBMNCs))))))
          (S
            (VP (TO to)
              (VP (VB screen)
                (NP (CD seven) (JJ different) (NN RT-PCR) (NNS assays)))
              (SBAR (IN in) (NN order)
                (S
                  (VP (TO to)
                    (VP (VB identify)
                      (NP
                        (NP (DT the) (JJS best) (NNS ones))
                        (PP (IN for)
                          (NP
                            (NP (NN inclusion))
                            (PP (IN in)
                              (NP
                                (NP (DT a) (NN panel))
                                (PP (IN for)
                                  (NP
                                    (NP (DT the) (JJ immunobead) (NN RT-PCR) (NN based) (NN detection))
                                    (PP (IN of)
                                      (NP (VBG circulating) (NN tumor) (NNS cells)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD used)
        (NP (NN breast) (NN cancer) (NN cell) (NNS lines))
        (PP (IN as)
          (NP
            (NP (DT the) (NN source))
            (PP (IN of)
              (NP (NN tumor) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP (NN breast) (NN cancer) (NN cell) (NNS lines))
          (VP (MD may)
            (VP (VB have)
              (NP
                (NP (JJ different) (NNS levels))
                (PP (IN of)
                  (NP
                    (NP (NN expression))
                    (PP (IN of)
                      (NP (NNS markers))))))
              (PP (VBN compared)
                (PP (TO to)
                  (NP (JJ disseminated) (NN breast) (NN cancer) (NNS cells))))))))
      (, ,)
      (NP
        (NP (NNS cells))
        (PP
          (PP (IN from)
            (NP (JJ different) (NNS individuals)))
          (, ,)
          (CC and)
          (RB even)
          (PP (IN within)
            (NP (DT an) (NN individual)))
          (, ,)))
      (VP (VBP are)
        (ADJP (JJ likely)
          (S
            (VP (TO to)
              (VP (VB display)
                (NP (JJ considerable) (NN heterogeneity))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD sought)
        (S
          (VP (TO to)
            (VP (VB overcome)
              (NP (DT this) (NN difficulty))
              (PP (IN by)
                (S
                  (VP (VBG using)
                    (NP
                      (NP (DT a) (NN number))
                      (PP (IN of)
                        (NP (NN cell) (NNS lines))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN use))
        (PP (IN of)
          (NP (NN cell) (NNS lines))))
      (VP (VBZ has)
        (NP
          (NP (DT the) (JJ great) (NN advantage))
          (PP (IN of)
            (S
              (VP (VBG providing)
                (NP (JJ reproducible) (NNS controls))
                (S
                  (VP (TO to)
                    (VP (VB test)
                      (NP
                        (NP (DT the) (NN sensitivity))
                        (PP (IN of)
                          (NP (DT the) (NN RT-PCR) (NNS assays)))
                        (PP (IN during)
                          (NP
                            (NP (NNS studies))
                            (PP (IN of)
                              (NP (NN patient) (NN material)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ immunobead) (NN enrichment) (NN step))
      (VP (VBZ relies)
        (PP (IN on)
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP
                (NP
                  (NP
                    (NP (DT an) (JJ epithelial) (NN cell) (NN adhesion) (NN molecule))
                    (PRN (-LRB- -LRB-)
                      (NP (NN EpCAM))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (JJ current) (NN gene) (NN symbol))
                      (, ,)
                      (NP (NN TACTSD1))
                      (, ,)
                      (NP (JJ tumor-associated) (NN calcium) (NN signal) (NN transducer) (CD 1)))
                    (-RRB- -RRB-)))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ is)
                      (VP (VBN recognized)
                        (PP (IN by)
                          (NP
                            (NP (DT an) (NN antibody))
                            (PP (IN on)
                              (NP (NNS immunobeads)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD considered)
        (NP (DT this))
        (S
          (VP (TO to)
            (VP (VB be)
              (NP (DT an) (JJ appropriate) (JJ positive) (NN control))
              (, ,)
              (SBAR (IN as)
                (S
                  (NP
                    (NP (DT any) (NN cell))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBZ is)
                          (VP (VBN detected)
                            (S
                              (VP (VBG using)
                                (NP (DT the) (NNS immunobeads)))))))))
                  (VP (MD should)
                    (VP (VB express)
                      (NP (DT the) (NN EpCAM) (NN gene)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT All))
          (PP (IN of)
            (NP (DT the) (NN breast) (NN cancer) (NN cell) (NNS lines))))
        (VP (VBD expressed)
          (NP (DT the) (NN EpCAM) (NN gene))))
      (CC and)
      (S
        (NP (DT no) (NN message))
        (VP (VBD was)
          (VP (VBN detected)
            (PP (IN in)
              (NP
                (NP (DT any))
                (PP (IN of)
                  (NP
                    (NP (CD 24) (NNS aliquots))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBD contained)
                          (NP (CD 100) (NN PBMNC)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Tests))
        (PP (IN of)
          (NP
            (NP (DT the)
              (NP
                (NP (JJ single) (NN tumor) (NN cell))
                (CC and)
                (NP (CD 100) (NN PBMNC)))
              (NNS aliquots))
            (PP (IN with)
              (NP (NN EpCAM))))))
      (VP (VBD showed)
        (SBAR (IN that)
          (S
            (NP (PRP it))
            (VP (VBD was)
              (ADVP (RB also))
              (VP (VBN expressed)
                (PP (TO to)
                  (NP (DT a) (JJ sufficient) (NN level)
                    (S
                      (VP (TO to)
                        (VP (VB enable)
                          (NP
                            (NP (NN detection))
                            (PP (IN of)
                              (NP (DT the) (NN tumor) (NN cell)))
                            (PP (IN in)
                              (NP (CD 31/35)
                                (PRN (-LRB- -LRB-)
                                  (NP (CD 89) (NN %))
                                  (-RRB- -RRB-))
                                (NNS cases))))
                          (PP (IN after)
                            (NP
                              (NP (CD 45) (NNS cycles))
                              (PP (IN of)
                                (NP (NN PCR) (NN amplification))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (ADVP (RB therefore))
      (VP (VB consider)
        (NP (NN EpCAM))
        (PP
          (NP
            (NP (DT a) (JJ useful) (NN addition))
            (PP (TO to)
              (NP (DT a) (NN marker) (NN panel))))
          (IN for)
          (NP
            (NP (DT the) (NN detection))
            (PP (IN of)
              (NP (NN breast) (NN tumor) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN sensitivity))
              (PP (IN with)
                (NP (DT this) (NN marker))))
            (VP (MD can)
              (VP (VB be)
                (VP (VBN improved)
                  (SBAR (IN if)
                    (S
                      (NP (JJR more) (NN PCR) (NNS cycles))
                      (VP (VBP are)
                        (VP (VBN performed))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Mucin) (CD 1) (-LRB- -LRB-) (NN MUC1) (-RRB- -RRB-))
      (VP (VBZ is)
        (NP
          (NP (DT another) (JJ epithelial) (NN glycoprotein))
          (VP (VBN expressed)
            (PP (IN in)
              (NP (NN breast) (JJ epithelial) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (NP
          (NP (DT a)
            (ADJP (RB commonly) (VBN used)
              (PP (IN if)
                (NP (JJ controversial))))
            (NN marker))
          (PP (IN for)
            (NP
              (NP (NN detection))
              (PP (IN of)
                (S
                  (VP (VBG circulating)
                    (NP (NN tumor) (NNS cells) (CD -LSB-5) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Recently))
      (, ,)
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN reported)
          (SBAR
            (WHPP (IN that)
              (WHNP (WDT that)))
            (S
              (NP
                (NP (JJ immunomagnetic) (NN separation))
                (VP (VBN followed)
                  (PP (IN by)
                    (NP (JJ MUC1-specific) (JJ real) (NN time) (NN RT-PCR)))))
              (VP (VBD allowed)
                (NP
                  (NP (DT the) (JJ semi-quantitative) (NN detection))
                  (PP (IN of)
                    (NP (VBG circulating) (JJ mammary) (NNS cells))))
                (SBAR (IN if)
                  (S
                    (NP
                      (NP (NN amplification))
                      (PP (IN above)
                        (NP
                          (NP (DT a) (NN cycle) (NN threshold) (NN value))
                          (PP (IN of)
                            (NP (CD 38))))))
                    (VP (VBD was)
                      (VP (VBN obtained)
                        (NP (CD -LSB-15) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Using)
          (NP (PRP$ our) (NN assay))))
      (, ,)
      (NP (NN MUC1) (NNS transcripts))
      (VP (VBD were)
        (VP (VBN detected)
          (PP (IN in)
            (NP
              (NP (NN 1/6) (CD 100) (NN PBMNC) (JJ only) (NNS samples))
              (CC and)
              (NP (NN 10/15) (NN tumor) (NN cell) (NNS samples)))))))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP we))
        (VP (VBD did) (RB not)
          (VP (VB use)
            (NP (JJ real-time) (NN PCR))
            (PP (IN for)
              (NP (PRP$ our) (NN assay)))))))
    (, ,)
    (S
      (S
        (NP
          (NP (DT the) (NN intensity))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ positive) (NNS bands))
              (PP (IN in)
                (NP (DT the) (NN PBMNC) (JJ only) (NNS samples))))))
        (VP (VBD was)
          (ADJP (JJ comparable)
            (PP (TO to)
              (NP
                (NP (DT that))
                (VP (VBN obtained)
                  (PP (IN with)
                    (NP (DT the) (NN tumor) (NN cell) (NNS samples)))))))))
      (CC and)
      (S
        (NP (PRP it))
        (VP (VBD was)
          (VP (VBN concluded)
            (SBAR (IN that)
              (S
                (NP
                  (NP (NN detection))
                  (PP (IN of)
                    (NP (NN MUC1) (NNS transcripts))))
                (VP (MD would)
                  (VP (VB result)
                    (PP (IN in)
                      (NP
                        (ADJP (RB too) (JJ many))
                        (ADJP
                          (ADJP (JJ false))
                          (ADJP (JJ positive)))
                        (NNS results)))
                    (S
                      (VP (TO to)
                        (VP (VBP warrant)
                          (NP
                            (NP (PRP$ its) (NN inclusion))
                            (PP (IN in)
                              (NP (PRP$ our) (NN panel)))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (PP (IN during)
        (NP
          (NP (DT the) (NN course))
          (PP (IN of)
            (NP (DT this) (NN study)))))
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN reported)
          (PP (IN that)
            (S
              (NP
                (NP (DT a) (NN majority))
                (PP (IN of)
                  (NP
                    (NP
                      (NP
                        (NP (NN CK))
                        (-LRB- -LRB-)
                        (CC +)
                        (-RRB- -RRB-)
                        (NP (NN /MUC1))
                        (-LRB- -LRB-)
                        (CC +)
                        (-RRB- -RRB-))
                      (NN tumor) (NNS cells))
                    (VP (VBG circulating)
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN blood))
                          (PP (IN of)
                            (NP
                              (NP (NNS patients))
                              (PP (IN with)
                                (NP (JJ advanced) (NN breast) (NN cancer)))))))))))
              (ADVP (RB also))
              (VP (VBD displayed)
                (NP
                  (NP (JJ apoptotic) (NNS features))
                  (PP (JJ such) (IN as)
                    (NP
                      (NP (DT an) (`` ``) (NN inclusion) (NN type) (NN ''))
                      (NP (NN cytokeratin) (NN staining) (NN pattern))
                      (CC and)
                      (NP (JJ nuclear) (NN condensation)))))
                (PP (IN with)
                  (NP
                    (NP (JJ apoptosis-related) (NN DNA) (NN strand) (NNS breaks))
                    (CD -LSB-16) (-RRB- -RSB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBD was)
        (VP (VBN concluded)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (JJ predictive) (NN value))
                (PP (IN of)
                  (NP (JJ such)
                    (NP
                      (NP (NN CK))
                      (-LRB- -LRB-)
                      (CC +)
                      (-RRB- -RRB-)
                      (NP (NN /MUC1))
                      (-LRB- -LRB-)
                      (CC +)
                      (-RRB- -RRB-))
                    (JJ positive) (NNS cells))))
              (VP (MD should)
                (VP (VB be)
                  (VP (VBN considered)
                    (ADVP (RB separately))))
                (SBAR
                  (WHADVP (WRB when))
                  (S
                    (VP (VBG analysing)
                      (NP (NN tumor) (NN cell) (NN dissemination)))))
                (, ,)
                (S
                  (ADVP (RB further))
                  (VP (VBG supporting)
                    (NP (PRP$ our) (NN decision)
                      (S
                        (VP (RB not) (TO to)
                          (VP (VB include)
                            (NP (NN MUC1))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (JJ Elevated) (NNS levels))
          (PP (IN of)
            (NP (NN serum) (NN carcinoembryonic) (NN antigenCEA))))
        (VP (VBP are)
          (ADVP (RB commonly))
          (VP (VBN used)
            (PP (IN as)
              (NP
                (NP (DT a) (JJ clinical) (NN tool))
                (PP (IN in)
                  (NP
                    (NP (DT the)
                      (NP (NN diagnosis))
                      (CC and)
                      (NP (NN monitoring)))
                    (PP (IN of)
                      (NP (NN metastasis))))))))))
      (CC but)
      (S
        (NP
          (NP (DT the) (NN use))
          (PP (IN of)
            (NP (NN CEA)))
          (PP (IN as)
            (NP (DT an) (JJ immunobead) (NN RT-PCR) (NN marker) (CD -LSB-17)))
          (-RRB- -RSB-))
        (VP (VBZ has)
          (VP (VBN given)
            (NP (VBG varying) (NNS results))))))
    (. .)))

(
  (S
    (S
      (NP (NN CEA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN considered)
            (S
              (VP (TO to)
                (VP (VB show)
                  (NP (DT no) (JJ diagnostic) (NN value))
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN RT-PCR) (NN marker))
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN detection))
                          (PP (IN of)
                            (NP (NNS micrometastases)))))))
                  (PP (IN because)
                    (S
                      (NP (PRP it))
                      (VP (VBZ is)
                        (VP (VBN expressed)
                          (PP (IN in)
                            (NP
                              (NP (DT the)
                                (NP (NN blood))
                                (CC and)
                                (NP (NN lymph) (NNS nodes)))
                              (PP (IN of)
                                (NP
                                  (NP (NNS patients))
                                  (PP (IN without)
                                    (NP (NN cancer) (NN -LSB-5)))))))))
                      (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (IN in)
        (NP
          (NP (DT a) (NN comparison))
          (PP (IN of)
            (NP
              (NP (JJ immunobead) (NN RT-PCR))
              (CC and)
              (NP (JJ regular) (NN RT-PCR) (NN amplification))))))
      (, ,)
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (JJ immunobead) (NN isolation))
              (VP (VBZ increases)
                (NP
                  (NP (DT the) (NN specificity))
                  (PP (IN of)
                    (NP (NN CEA -LSB-8)))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (VP (VBG Using)
        (NP
          (NP (CD 55) (NN PCR) (NNS cycles))
          (PP (IN for)
            (NP (NN CEA))))))
    (, ,)
    (NP (PRP we))
    (VP
      (VP (VBD found)
        (NP (NN amplification))
        (PP (IN in)
          (NP
            (NP (NN none))
            (PP (IN of)
              (NP (DT the) (CD PBMNC) (JJ only) (NNS samples))))))
      (CC and)
      (VP (VBN gained)
        (NP (DT a) (JJ positive) (NN result))
        (PP (IN for)
          (NP
            (NP (CD 45) (NN %))
            (PP (IN of)
              (NP
                (NP
                  (NP (DT the) (JJ single) (NN tumor) (NN cell) (NNS samples))
                  (NP (PRP we)))
                (VP (VBN tested))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (NN CEA))
      (VP (VBZ appears)
        (S
          (VP (TO to)
            (VP (VB be)
              (NP
                (NP (DT a)
                  (ADJP (RB very) (JJ useful))
                  (NN marker))
                (SBAR
                  (WHADVP (WRB when))
                  (S
                    (NP (JJ immunobead) (NN enrichment))
                    (VP (VBZ is)
                      (VP (VBN performed)
                        (ADVP
                          (ADVP (RB prior))
                          (PP (TO to)
                            (NP (NN RT-PCR))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Epidermal) (NN growth) (NN factor) (NN receptor))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NN EGFR))
            (, ,)
            (NP (NN HER1))
            (, ,)
            (NP (NN ErbB1)))
          (-RRB- -RRB-)))
      (VP (VBZ is)
        (NP
          (NP (DT a) (NN tyrosine) (NN kinase))
          (SBAR
            (WHNP (WP$ whose) (NN activation))
            (S
              (VP (VBZ plays)
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN regulation))
                    (PP (IN of)
                      (NP
                        (NP
                          (NP (NN cell) (NN proliferation))
                          (, ,)
                          (NP (NN differentiation))
                          (CC and)
                          (NP (NN survival)))
                        (PP (IN with)
                          (NP
                            (NP (DT a) (JJ pivotal) (NN role))
                            (PP (IN in)
                              (NP
                                (NP
                                  (NP (NN maintenance))
                                  (CC and)
                                  (NP (NN repair)))
                                (PP (IN of)
                                  (NP (JJ epithelial) (NNS tissues)))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN EGFR))
      (VP (VBZ is)
        (VP (VBN overexpressed)
          (PP (IN in)
            (NP
              (NP (CD 50–70) (NN %))
              (PP (IN of)
                (NP
                  (NP
                    (NP (JJ human) (JJ primary) (NN breast))
                    (, ,)
                    (NP (NN lung))
                    (, ,)
                    (CC and)
                    (NP (NN colon)))
                  (NNS carcinomas)))))
          (NP (CD -LSB-18))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN study))
        (VP (VBG using)
          (NP
            (NP
              (NP (JJ nested) (NN RT-PCR))
              (CC and)
              (NP (NN Southern) (NN blotting)))
            (VP (TO to)
              (VP (VB detect)
                (NP (NN EGFR) (NNS transcripts))
                (PP (IN in)
                  (NP
                    (NP (NN blood) (NNS samples))
                    (PP (IN from)
                      (NP
                        (NP (NNS patients))
                        (PP (IN with)
                          (NP (JJ metastatic) (NN colon) (NN cancer))))))))))))
      (VP (VBD found)
        (SBAR (IN that)
          (S
            (NP
              (NP (CD 10.5) (NN %))
              (PP (IN of)
                (NP (JJ healthy) (NNS donors))))
            (VP (VBD were)
              (ADJP (JJ positive))
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ suggests)
                    (SBAR (IN that)
                      (S
                        (NP (PRP$ their) (NN assay))
                        (VP (VBD detected)
                          (NP (JJ illegitimate) (NN transcription)))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (NN none))
        (PP (IN of)
          (NP
            (NP (DT the) (CD 27) (NN PBMNC) (JJ only) (NNS aliquots))
            (VP (VBN tested)
              (PP (IN in)
                (NP (PRP$ our) (NN assay)))))))
      (VP (VBD yielded)
        (NP
          (NP (NN EGFR) (NN amplification) (NNS products))
          (CC and)
          (NP
            (NP (CD 19/43))
            (PRN (-LRB- -LRB-)
              (NP (CD 44) (NN %))
              (-RRB- -RRB-))))))
    (S
      (NP (JJ single) (NN tumor) (NNS cells))
      (VP (VBD were)
        (VP (VBN detected))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT A) (NN comparison))
          (PP (IN of)
            (NP
              (NP (DT the) (NNS results))
              (VP (VBN obtained)
                (PP (IN for)
                  (NP
                    (NP (DT the) (CD two) (NN ER) (JJ positive) (NN cell) (NNS lines))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 6/20))
                      (-RRB- -RRB-)))))))
          (PP (IN with)
            (NP
              (NP (DT those))
              (VP (VBN obtained)
                (PP (IN for)
                  (NP
                    (NP (DT the) (CD two) (NN ER) (JJ negative) (NN cell) (NNS lines))
                    (PRN (-LRB- -LRB-)
                      (NP (NN 13/23))
                      (-RRB- -RRB-))))))))
        (VP (VBZ suggests)
          (SBAR (IN that)
            (S
              (NP (NN ER) (NN status))
              (VP (MD will)
                (VP (VB affect)
                  (NP
                    (NP (DT the) (NN efficacy))
                    (PP (IN of)
                      (NP (DT this) (NN marker))))))))))
      (CC but)
      (S
        (NP (PRP it))
        (VP (VBZ remains)
          (NP (DT a) (JJ useful) (NN marker)))))
    (. .)))

(
  (S
    (S
      (NP (NN Mammaglobin) (CD 1) (-LRB- -LRB-) (NN MGB1) (-RRB- -RRB-) (NN expression))
      (VP
        (VP (VBZ is)
          (ADJP (JJ limited)
            (PP (TO to)
              (NP (JJ mammary) (NN epithelium)))))
        (CC and)
        (VP (VBZ is)
          (ADVP (RB often))
          (VP (VBN up-regulated)
            (PP (IN in)
              (NP (JJ human) (NN breast) (NN cancer) (CD -LSB-20) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN gene))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN localised)
            (PP (TO to)
              (NP (NN chromosome) (CD 11q13)))
            (PP (IN in)
              (NP
                (NP (DT a) (NN region))
                (VP
                  (ADVP (RB frequently))
                  (VBN amplified)
                  (PP (IN in)
                    (NP (NN breast) (NN cancer))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Using)
          (NP (JJ nested) (NN RT-PCR))))
      (, ,)
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NN MGB1) (NNS transcripts))
              (VP (VBP are)
                (ADJP (JJ detectable)
                  (PP (IN in)
                    (NP
                      (NP (NN blood))
                      (PP (IN from)
                        (NP (NN breast) (NN cancer) (NNS patients) (CD -LSB-21) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (NP
      (NP
        (NP (NNP Marchetti) (FW et) (FW al))
        (. .))
      (, ,)
      (NP (-LRB- -LRB-) (CD 2001) (-RRB- -RRB-)))
    (VP
      (VP (VBD analysed)
        (NP
          (NP (NN lymph) (NNS nodes))
          (PP (IN from)
            (NP (NN breast) (NN cancer)
              (CC and)
              (JJ normal) (NNS patients)))))
      (CC and)
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NN MGB1))
            (VP (VBZ is)
              (NP
                (NP (DT a)
                  (ADJP
                    (ADJP (RBR more) (JJ sensitive))
                    (CC and)
                    (ADJP (RBR more) (JJ specific)))
                  (NN RT-PCR) (NN marker))
                (PP (IN than)
                  (NP
                    (NP (DT a) (NN panel))
                    (PP (IN of)
                      (NP
                        (NP (CD six) (JJ other) (NNS markers))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBD included)
                              (NP
                                (NP (NN CEA))
                                (, ,)
                                (NP (NN CK19))
                                (CC and)
                                (NP (NN MUC1-LSB-22))))
                            (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN MGB1) (NNS transcripts))
      (VP (VBD were) (RB not)
        (VP (VBN detected)
          (PP (IN by)
            (NP (PRP us)))
          (PP (IN in)
            (NP
              (NP (DT any))
              (PP (IN of)
                (NP (DT the) (NN PBMNC) (JJ only) (NNS aliquots))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In)
          (NP (PRP$ our) (NNS hands)))
        (, ,)
        (NP (NN MGB1) (NNS transcripts))
        (VP (VBD were)
          (ADVP (RB only))
          (VP (VBN detected)
            (PP (IN in)
              (NP
                (NP
                  (NP (CD 9/35))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 26) (NN %))
                    (-RRB- -RRB-)))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ single) (NN tumor) (NNS cells))
                    (VP (VBN tested)))))))))
      (CC but)
      (S
        (SBAR (IN because)
          (S
            (NP (DT this) (NN marker))
            (VP (VBZ is)
              (ADJP (JJ mammary-specific)))))
        (, ,)
        (NP
          (NP (PRP$ its) (NN inclusion))
          (PP (IN in)
            (NP
              (NP (DT a) (NN panel))
              (PP (IN of)
                (NP (NN RT-PCR) (NNS markers))))))
        (VP (VBZ is)
          (VP (VBN warranted)))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN sensitivity))
              (PP (IN with)
                (NP (DT this) (NN marker))))
            (VP (MD can)
              (VP (VB be)
                (VP (VBN improved)
                  (SBAR (IN if)
                    (S
                      (NP (JJR more) (NN PCR) (NNS cycles))
                      (VP (VBP are)
                        (VP (VBN performed))))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN ELF3))
      (, ,)
      (VP
        (ADVP (RB also))
        (VBN known)
        (PP (IN as)
          (ADJP (JJ Epithelial-Specific)
            (PP (IN with)
              (NP
                (NP (NN serine) (NN bo) (NN X))
                (PRN (-LRB- -LRB-)
                  (NP (NN ESX))
                  (-RRB- -RRB-)))))))
      (, ,))
    (VP
      (VP (VBZ is)
        (NP
          (NP (DT a) (NN member))
          (PP (IN of)
            (NP
              (NP (DT the) (NN Ets) (JJ multigene) (NN family))
              (PP (IN of)
                (NP (JJ transcriptional) (NNS regulators)))))))
      (CC and)
      (VP (VBZ is)
        (VP (VBN localised)
          (PP (TO to)
            (NP (NN chromosome) (CD 1q32)))
          (PP (IN in)
            (NP
              (NP (DT a) (NN region))
              (VP (VBN known)
                (S
                  (VP (TO to)
                    (VP (VB be)
                      (VP (VBN amplified)
                        (PP (IN in)
                          (NP
                            (NP (CD 50) (NN %))
                            (PP (IN of)
                              (NP (JJ early) (NN breast) (NNS cancers)))))
                        (S
                          (LST (CD -LSB-11,23) (-RRB- -RSB-))
                          (NP (NN .ELF3) (NN mRNA) (NN expression))
                          (VP (VBZ is)
                            (ADJP (JJ restricted)
                              (PP (TO to)
                                (NP
                                  (NP (NNS tissues))
                                  (PP (IN of)
                                    (NP (JJ epithelial) (NN origin)))
                                  (, ,)
                                  (PP (VBG including)
                                    (NP
                                      (NP
                                        (ADJP
                                          (ADJP (JJ normal))
                                          (CC and)
                                          (ADJP (JJ malignant)))
                                        (JJ human) (JJ mammary) (JJ ductal) (NN epithelium))
                                      (PP (IN with)
                                        (NP
                                          (NP (DT no) (NN expression))
                                          (VP (VBN reported)
                                            (PP (IN in)
                                              (NP (JJ lympho-haematopoietic) (NNS tissues)))))))))))))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (PRP$ our) (NN assay)))
    (, ,)
    (NP (JJ faint) (NNS bands))
    (VP (VBD were)
      (ADJP (JJ visible)
        (PP (IN at)
          (NP (CD 188) (NN bp))))
      (PP (CC both)
        (PP (IN after)
          (NP
            (NP (CD 45) (NNS cycles))
            (PRN (-LRB- -LRB-)
              (NP (NN 1/6))
              (-RRB- -RRB-))))
        (CC and)
        (PP (IN after)
          (NP
            (NP (CD 55) (NNS cycles))
            (PRN (-LRB- -LRB-)
              (NP (NN 5/30))
              (-RRB- -RRB-)))))
      (PP (IN in)
        (NP (DT the) (NN PBMNC) (JJ only) (NNS aliquots))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (NP
        (NP (DT the) (JJ strong) (NN intensity))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS bands))
            (PP (IN for)
              (NP
                (NP
                  (NP
                    (NP (DT the) (NN 40/43))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 93) (NN %))
                      (-RRB- -RRB-)))
                  (NNS samples))
                (PP (IN with)
                  (NP (DT a) (JJ single) (NN tumor) (NN cell))))))))
      (VP (VBD was)
        (VP (VBN considered)
          (S
            (ADJP (JJ indicative)
              (PP (IN of)
                (NP
                  (NP (DT a) (JJ positive) (NN result))
                  (PP (IN in)
                    (NP (DT these) (NNS cases))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Decreasing)
          (NP (DT the) (NN cycle) (NN number))
          (PP (TO to)
            (NP
              (NP (CD 35))
              (VP
                (VP (VBD eliminated)
                  (NP
                    (NP (DT the) (JJ weak) (NN band))
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN PBMNC) (RB only) (NNS aliquots))
                        (PRN (-LRB- -LRB-)
                          (NP (NN 0/15))
                          (-RRB- -RRB-))))))
                (, ,)
                (CC yet)
                (ADVP (RB still))
                (VP (VBD allowed)
                  (NP
                    (NP (JJ consistent) (NN detection))
                    (PP (IN of)
                      (NP (DT the) (NN tumor) (NNS cells))))
                  (PP (IN in)
                    (NP (PRP$ our) (NN assay)))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 15/16) (: –) (CD 94) (NN %))
                    (-RRB- -RRB-))))))))
      (CC and)
      (S
        (ADVP (RB therefore))
        (NP (NN ELF3))
        (VP (VBZ is)
          (NP
            (NP (DT a) (JJ useful) (NN marker))
            (PP (IN for)
              (NP
                (NP (NN inclusion))
                (PP (IN in)
                  (NP (PRP$ our) (NN panel)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN EphB4))
      (VP
        (VP (VBZ is)
          (NP
            (NP (DT a) (NN member))
            (PP (IN of)
              (NP
                (NP (DT the) (NN Eph) (NN family))
                (PP (IN of)
                  (NP (NN receptor) (NN protein) (NN tyrosine) (NNS kinases)))))))
        (CC and)
        (VP (VBZ has)
          (ADVP (RB recently))
          (VP (VBN been)
            (VP (VBN reported)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (VP (VBN up-regulated)
                      (PP (IN in)
                        (NP
                          (NP (NNS cancers))
                          (PP (IN from)
                            (NP
                              (NP (NN prostate))
                              (, ,)
                              (NP (NN breast))
                              (, ,)
                              (NP (NN endometrium))
                              (, ,)
                              (NP (NN lung))
                              (CC and)
                              (NP (NN colon))
                              (NP (NN -LSB-12,24-27))
                              (-RRB- -RSB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB play)
                (NP (DT an) (JJ important) (NN role))
                (PP (IN in)
                  (NP
                    (NP (DT the)
                      (NP (NN development))
                      (CC and)
                      (NP (NN oncogenesis)))
                    (PP (IN of)
                      (NP (JJ various) (NNS tissues)))
                    (PP (IN through)
                      (NP
                        (NP (NNS modifications))
                        (PP (TO to)
                          (NP
                            (NP (JJ cell-cell) (NN communication))
                            (CC and)
                            (NP (NN adhesion))))))))))))))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP (NN EphB4))
        (VP (VBD was)
          (VP (VBN detected)
            (PP (IN in)
              (NP (DT some) (NN PBMNC) (NN cell) (JJ only) (NNS controls)))
            (PP (IN at)
              (NP (CD 55) (NNS cycles)))))))
    (NP
      (NP (DT the) (NN level))
      (PP (IN of)
        (NP
          (NP (NN intensity))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ corresponding) (NNS bands))
              (PP (IN on)
                (NP (NN agarose) (NNS gels))))))))
    (VP (VBD was)
      (UCP
        (ADJP (JJ low))
        (CC and)
        (VP (VBG decreasing)
          (NP (DT the) (NN cycle) (NN number))
          (PP (TO to)
            (NP
              (NP (CD 45))
              (VP (VBD resulted)
                (PP (IN in)
                  (NP
                    (NP (DT no) (JJ positive) (NNS samples))
                    (PP (RP out)
                      (PP (IN of)
                        (NP (CD 21) (NNS tests))))))))))))
    (. .)))

(
  (S
    (S
      (VP (VBG Using)
        (NP (NN EphB4) (JJ specific) (NNS primers))
        (PP (IN with)
          (NP (CD 45) (NNS cycles)))))
    (NP (PRP we))
    (VP (MD could)
      (VP (VB detect)
        (NP
          (NP (CD 77.5) (NN %))
          (PP (IN of)
            (NP
              (NP (JJ single) (NN tumor) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NN 31/40))
                (-RRB- -RRB-)))))
        (S
          (VP (VBG proving)
            (NP (DT this))
            (S
              (VP (TO to)
                (VP (VB be)
                  (NP
                    (NP (DT an) (JJ useful) (NN marker))
                    (PP (IN in)
                      (NP (DT this) (NN assay)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ various) (NNS markers))
        (VP (VBN used)))
      (ADVP (RB here))
      (VP (VBP show)
        (NP
          (NP (JJ different) (NNS degrees))
          (PP (IN of)
            (NP (NN heterogeneity))))
        (VP (VBZ i.e)
          (NP
            (NP (DT the) (NNS numbers))
            (PP (IN of)
              (NP (JJ single) (NN tumor) (NNS cells))))
          (SBAR (IN that)
            (S
              (NP (PRP they))
              (VP (VBP are)
                (VP (VBN detected)
                  (PP (IN in)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (NP (DT the)
        (ADJP (RBR more) (JJ heterogeneous))
        (NNS markers))
      (ADVP (RB also))
      (VP (VBD gave)
        (NP (DT the) (JJS least) (JJ false) (NNS positives))
        (PP (IN in)
          (NP (DT the) (NNS controls)))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ unclear))
        (SBAR (IN whether)
          (S
            (NP (DT this))
            (VP (VBZ is)
              (ADJP
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN sensitivity))
                      (PP (IN of)
                        (NP (DT the) (NN test))))))
                (CC or)
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP
                      (NP (JJ stochastic) (NNS differences))
                      (PP (IN in)
                        (SBAR (IN whether)
                          (S
                            (NP (DT a) (NN cell))
                            (VP (VBZ expresses)
                              (NP
                                (NP (DT a) (NN transcript))
                                (CC or)
                                (RB not)))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (NN Heterogeneity))
          (PP (IN at)
            (NP (DT the) (JJ single) (NN cell) (NN level))))
        (VP (MD must)
          (VP (VB be)
            (VP (VBN taken)
              (PP (IN into)
                (NP (NN account)))
              (SBAR
                (WHADVP (WRB when))
                (S
                  (VP (VBG designing)
                    (NP (DT an) (NN RT-PCR) (NN assay)))))))))
      (CC and)
      (S
        (NP (DT this) (NN study))
        (VP (VBZ is)
          (NP (DT the) (JJ first) (CD one))
          (S
            (VP (TO to)
              (VP (VB address)
                (NP (DT this))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBG Using)
          (NP
            (NP (DT a) (NN panel))
            (PP (IN of)
              (NP (JJ several) (NNS markers))))))
      (VP (MD will)
        (VP (VB reduce)
          (NP
            (NP (DT this) (NN source))
            (PP (IN of)
              (NP (NN error)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN seen)
            (PP (IN in)
              (NP (NN table) (CD 3)))
            (SBAR
              (WHADVP (WRB where))
              (S
                (NP (RB nearly) (DT every) (NN tumour) (NN cell))
                (VP (VBZ is)
                  (ADJP (JJ positive)
                    (PP (IN for)
                      (NP
                        (QP (JJR more) (IN than) (CD one))
                        (NN marker)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (CD One) (NN T-47D) (NN cell))
        (VP (VBZ is)
          (ADJP (JJ negative)
            (PP (IN for)
              (NP
                (NP (DT all) (CD 5) (NNS markers))
                (VP (VBN tested)))))))
      (CC and)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (ADJP (JJ possible))
          (SBAR (IN that)
            (S
              (NP (DT this) (NN cell))
              (VP (VBD was) (RB not)
                (ADJP (JJ viable))
                (PP (IN at)
                  (NP
                    (NP (DT the) (NN time))
                    (PP (IN of)
                      (NP (NN selection)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN need)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP (CC both)
                (ADJP (JJ specific))
                (CC and)
                (ADJP (JJ sensitive)))))))
      (VP (MD may)
        (VP (VBP entail)
          (S
            (VP (VBG finding)
              (NP
                (NP (DT a) (NN balance))
                (PP (IN between)
                  (NP (DT the)
                    (NP (NN specificity))
                    (CC and)
                    (NP (NN sensitivity))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (PRP$ Our) (NNS findings))
        (PP (IN in)
          (NP (DT the) (NN PBMNC))))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (JJ illegitimate) (NN transcription))
            (VP (VBZ occurs)
              (PP (IN in)
                (NP
                  (NP (DT all) (NNS cells))
                  (CONJP (RB rather) (IN than))
                  (NP (DT a) (NN subset)))))))))
    (. .)))

(
  (S
    (S
      (SBAR
        (WHADVP (WRB When))
        (S
          (S
            (NP
              (NP (JJ large) (NNS numbers))
              (PP (IN of)
                (NP (NNS cells))))
            (VP (VBP are)
              (ADJP (JJ present))))
          (CC or)
          (S
            (NP (DT the) (NN assay))
            (VP (VBZ is)
              (ADJP (RB very) (JJ sensitive))))))
      (, ,)
      (NP (JJ false) (NNS positives))
      (VP (MD will)
        (VP (VB be)
          (ADJP (JJ common)))))
    (. .)))

(
  (S
    (S
      (NP (NN ELF3))
      (VP (VBD had)
        (NP
          (NP (DT a)
            (ADJP (RB fairly) (JJ high))
            (JJ false) (JJ positive) (NN rate))
          (PP (IN of)
            (NP
              (NP (NN amplification))
              (PP (IN in)
                (NP (NN PBMNC))))))
        (PP (IN at)
          (NP (CD 45) (NNS cycles)))
        (PP
          (ADVP (RB presumably))
          (JJ due) (TO to)
          (S
            (VP (VBG detecting)
              (NP (JJ illegitimate) (NN transcription))
              (PP (IN in)
                (NP
                  (NP (DT a)
                    (ADJP (RB very) (JJ small))
                    (NN number))
                  (PP (IN of)
                    (NP (DT these) (NNS cells))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN ELF3))
      (VP (VBD was)
        (NP
          (NP (CD one))
          (PP (IN of)
            (NP
              (NP (DT the)
                (ADJP (RBR more) (JJ robust))
                (NNS markers))
              (VP (VBG giving)
                (NP
                  (NP
                    (ADJP (RB very) (JJ strong))
                    (NN amplification))
                  (PP (IN of)
                    (NP (JJ single) (NN tumour) (NNS cells))))
                (PP (IN at)
                  (NP (CD 45) (NNS cycles)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Amplification))
        (PP (IN from)
          (NP (DT the) (NNS controls))))
      (VP (VBD was)
        (VP (VBN eliminated)
          (SBAR
            (WHADVP (WRB when))
            (S
              (NP
                (NP
                  (QP (RB only) (CD 35))
                  (NNS cycles))
                (PP (IN of)
                  (NP (NN amplification))))
              (VP (VBD were)
                (VP (VBN performed))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Because)
        (S
          (NP
            (NP (RB only) (DT a) (JJ small) (NN amount))
            (PP (IN of)
              (NP (NN product))))
          (VP (VBD was)
            (VP (VBN amplified)
              (PP (IN after)
                (NP (CD 45) (NNS cycles)))
              (PP (IN in)
                (NP (DT these) (NNS controls)))))))
      (NP (PRP we))
      (VP (MD could)
        (VP (VB distinguish)
          (NP
            (NP (NNS samples))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBD contained)
                  (NP
                    (NP (NN tumor) (NNS cells))
                    (CC and)
                    (NP
                      (NP (DT those))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (VBD did)
                            (ADVP (RB not))
                            (PP (IN through)
                              (NP
                                (NP (NN comparison))
                                (PP (IN of)
                                  (NP
                                    (NP (DT the) (NN intensity))
                                    (PP (IN of)
                                      (NP (NNS bands)))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ suggests)
        (SBAR (IN that)
          (S
            (NP
              (ADJP
                (ADJP (DT this))
                (CC and)
                (ADJP (JJ similar)))
              (NNS markers))
            (VP (MD will)
              (VP (VB be)
                (ADJP (JJ useful))
                (PP (IN in)
                  (NP
                    (NP (DT a) (JJ real-time) (NN PCR) (NN methodology))
                    (SBAR
                      (WHADVP (WRB where))
                      (S
                        (NP (JJ positive) (NNS signals))
                        (VP (MD can)
                          (VP (VB be)
                            (ADVP (RBR more) (RB readily))
                            (VP (VBN differentiated)
                              (PP (IN from)
                                (NP (NN background) (NNS signals) (CD -LSB-15) (-RRB- -RSB-))))))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN As)
        (S
          (VP (VBN mentioned))))
      (, ,)
      (NP (CD one) (NN question))
      (VP (VBZ is)
        (SBAR (IN whether)
          (S
            (NP (NN cell) (NNS lines))
            (VP (VBP are)
              (ADJP (RB truly) (JJ representative)
                (PP (IN of)
                  (S
                    (VP (VBG circulating)
                      (NP (NN tumor) (NNS cells)))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT A) (JJ large) (NN number))
          (PP (IN of)
            (NP (VBG circulating) (NN tumor) (NNS cells))))
        (VP (VBP are)
          (VP (VBN believed)
            (S
              (VP (TO to)
                (VP (VB be)
                  (PP (IN in)
                    (NP (NN G0) (NN -LSB-1) (-RRB- -RSB-)))))))))
      (, ,) (IN whereas)
      (S
        (NP
          (NP (DT the) (NN cell) (NN line) (NNS controls))
          (VP (VBN used)))
        (VP (VBP are)
          (PP (IN from)
            (NP (NN log) (NN phase) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD compared)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP (NN ELF3))
              (, ,)
              (NP (NN EphB4))
              (CC and)
              (NP (NN EGFR))))
          (PP (IN in)
            (NP
              (NP (NNS cells))
              (VP (VBN grown)
                (PP
                  (PP (IN under)
                    (NP
                      (NP (NNS conditions))
                      (PP (IN of)
                        (NP (NN serum) (NN starvation)))))
                  (, ,)
                  (PP (IN during)
                    (NP (NN log) (NN phase)))
                  (CC and)
                  (PP (IN at)
                    (NP
                      (NP (JJ full) (NN confluence))
                      (PRN (-LRB- -LRB-)
                        (S
                          (NP (NNS data))
                          (VP (RB not) (VBN shown)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VB saw)
        (NP (DT no) (JJ appreciable) (NN difference))
        (PP (IN in)
          (NP
            (NP (DT the) (NN expression) (NNS levels))
            (PP (IN of)
              (NP
                (NP (DT any))
                (PP (IN of)
                  (NP (DT these) (CD 3) (NNS genes)))))))
        (PP (IN under)
          (NP
            (NP (DT any))
            (PP (IN of)
              (NP
                (NP (DT the) (NNS conditions))
                (VP (VBN tested))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Whereas)
        (S
          (NP (PRP it))
          (VP (VBZ is)
            (ADJP (JJ difficult)
              (S
                (VP (TO to)
                  (VP (VB model)
                    (NP
                      (NP (DT the) (JJ clinical) (NN situation))
                      (, ,)
                      (SBAR
                        (WHADVP (WRB where))
                        (S
                          (NP
                            (NP (NNS patterns))
                            (PP (IN of)
                              (NP (NN gene) (NN expression))))
                          (VP (VBP are)
                            (ADJP (JJ likely)
                              (S
                                (VP (TO to)
                                  (VP (VB be)
                                    (ADJP (JJ heterogeneous)))))))))))))))))
      (, ,)
      (NP
        (NP (DT the) (NN assay))
        (VP (VBN presented)
          (PP (IN in)
            (NP (DT this) (NN communication)))))
      (VP (VBZ is)
        (ADJP (JJ useful)
          (PP
            (PP (IN for)
              (S
                (VP (VBG testing)
                  (NP (JJ potential) (NN RT-PCR) (NNS markers)))))
            (CC and)
            (PP (IN as)
              (NP
                (NP (DT a) (JJ meaningful) (NN control))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN determination))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN presence))
                        (PP (IN of)
                          (NP (JJ disseminated) (NN tumor) (NNS cells)))
                        (PP (IN in)
                          (NP (JJ clinical) (NNS samples)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB fully))
          (VP (VB validate)
            (NP (DT these) (NNS markers)))))
      (, ,)
      (NP
        (NP (DT a) (JJ clinical) (NN study))
        (VP (VBG using)
          (NP
            (ADJP (RB immunomagnetically) (VBN enriched))
            (NNS cells))
          (PP (IN from)
            (NP (NNS patients)))))
      (VP (VBZ is)
        (VP (VBN needed))))
    (. .)))

(
  (S
    (S
      (NP (PDT Such) (DT a) (NN study))
      (VP (VBZ is)
        (ADVP (RB currently))
        (PP (IN in)
          (NP (NN progress)))))
    (. .)))

(
  (S
    (NP (NNS Conclusions))))

(
  (S
    (S
      (NP (JJ Immunobead) (NN RT-PCR))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ powerful) (NN methodology))
          (PP (IN for)
            (NP
              (NP (DT the) (NN detection))
              (PP (IN of)
                (NP (JJ disseminated) (NN carcinoma) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP need)
        (NP
          (NP (NN RT-PCR) (NNS assays))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBP are)
                (ADJP (JJ sensitive) (RB enough)
                  (S
                    (VP (TO to)
                      (VP (VB detect)
                        (NP
                          (NP
                            (ADJP (RB very) (JJ low))
                            (NNS numbers))
                          (PP (IN of)
                            (NP (JJ captured) (NN carcinoma) (NNS cells)))
                          (S
                            (SBAR (IN As)
                              (S
                                (NP (JJ haematopoietic) (NNS cells))
                                (VP (MD may)
                                  (VP (VB be)
                                    (ADVP (RB non-specifically))
                                    (VP (VBN retained)
                                      (PP (IN during)
                                        (NP
                                          (NP (JJ immunomagnetic) (NN enrichment))
                                          (PP (IN of)
                                            (NP (JJ epithelial) (NNS cells))))))))))
                            (, ,)
                            (NP (DT these) (NN RT-PCR) (NNS markers))
                            (ADVP (RB also))
                            (VP (VBP need)
                              (S
                                (VP (TO to)
                                  (VP (VB be)
                                    (VP (VBN tested)
                                      (PP (IN for)
                                        (NP (PRP$ their) (NN specificity))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN set))
        (PP (IN of)
          (NP (NN RT-PCR) (NNS markers))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN tested)
            (PP (IN for)
              (NP (PRP$ their) (NN ability)
                (S
                  (VP (TO to)
                    (VP (VB detect)
                      (NP
                        (NP (DT a) (JJ single) (NN carcinoma) (NN cell))
                        (VP (VBG using)
                          (NP
                            (NP (DT a) (JJ single) (NN round))
                            (PP (IN of)
                              (NP
                                (NP
                                  (NP (NN PCR))
                                  (CC and)
                                  (NP (NN ethidium) (NN bromide)))
                                (NN visualization)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN identified)
          (NP
            (NP (CD six) (JJ useful) (NNS markers))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP include)
                  (NP
                    (NP
                      (NP (DT the)
                        (ADJP (RB previously) (VBN described))
                        (NNS markers))
                      (NP
                        (NP (NN EpCAM))
                        (, ,)
                        (NP (NN EGFR))
                        (, ,)
                        (NP (NN CEA))
                        (CC and)
                        (NP (NN MGB1))))
                    (CONJP (RB as) (RB well) (IN as))
                    (NP
                      (NP (CD two) (JJ novel) (NNS markers))
                      (NP
                        (NP (NN EphB4))
                        (, ,)
                        (CC and)
                        (NP (NN ELF3))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT This) (NN panel))
          (PP (IN of)
            (NP (NNS markers))))
        (VP (MD should)
          (VP (VB allow)
            (NP
              (NP (DT the) (NN detection))
              (PP (IN of)
                (NP
                  (ADJP (RB virtually) (DT every))
                  (NN tumor) (NN cell)))))))
      (CC and)
      (S
        (NP (DT this) (NN means)
          (SBAR (IN that)
            (S
              (NP (DT a) (JJ positive) (NN result))
              (VP (MD will)
                (VP (VB be)
                  (VP (VBN obtained)
                    (NP (DT each) (NN time)
                      (NP (DT an) (JJ immunobead) (NN harvest)))))))))
        (VP (VBZ has)
          (VP (VBN captured)
            (NP
              (QP (IN at) (JJS least) (CD one))
              (NN breast) (NN cancer) (NN cell))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJS Most))
        (PP (IN of)
          (NP (DT these) (NNS markers))))
      (VP (MD will)
        (ADVP (RB also))
        (VP (VB be)
          (ADJP (JJ useful)
            (PP (IN in)
              (NP
                (NP (DT the) (NN analysis))
                (PP (IN of)
                  (NP
                    (NP (JJ other) (NNS carcinomas))
                    (PP (JJ such) (IN as)
                      (NP
                        (NP (NN colon))
                        (, ,)
                        (NP (NN lung))
                        (CC and)
                        (NP (NN prostate))))))))))))
    (. .)))

(
  (S
    (NP (VBG Competing) (NNS interests))))

(
  (S
    (S
      (NP (NN None))
      (VP (VBD declared)))
    (. .)))

(
  (S
    (NP (NN Pre-publication) (NN history))))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ pre-publication) (NN history))
        (PP (IN for)
          (NP (DT this) (NN paper))))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN accessed)
            (ADVP (RB here))))))
    (: :)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP (CD seven) (NN RT-PCR) (NNS markers)))
        (PP (IN in)
          (NP
            (NP (DT a) (NN panel))
            (PP (IN of)
              (NP (CD seven) (NN breast) (NN cancer) (NN cell) (NNS lines))))))
      (. .))))

(
  (S
    (S
      (S
        (NP (DT Each) (NN marker))
        (VP (VBZ is)
          (VP (VBN shown)
            (PP (IN in)
              (NP (DT a) (JJ separate) (NN panel))))))
      (CC and)
      (S
        (NP
          (NP (DT the) (NN size))
          (PP (IN of)
            (NP (DT the) (VBN amplified) (NN product))))
        (VP (VBZ is)
          (VP (VBN indicated)
            (SBAR (IN in)
              (S
                (S
                  (NP
                    (NP
                      (NP (NN base) (NNS pairs))
                      (PRN (-LRB- -LRB-)
                        (NP (NN bp))
                        (-RRB- -RRB-)))
                    (NN M))
                  (VP (VBZ indicates)
                    (NP (DT the) (NN pUC19/HpaII) (NN marker))))
                (, ,)
                (S
                  (NP (NN -ve))
                  (VP (VBZ indicates)
                    (NP (DT the) (NN RT-PCR) (JJ negative) (NN control))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Weak) (JJ genomic) (NN or) (NN primer) (NN dimer) (NNS bands))
      (VP (VBP are)
        (VP (VBN seen)
          (PP (IN for)
            (NP (DT some) (NNS RT-PCRs))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 2))
      (: :)
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP (CD seven) (NN RT-PCR) (NNS markers)))
        (PP (IN in)
          (NP
            (NP (CD 5) (JJ separate) (JJ single) (NN MDA-MB-453) (NNS cells))
            (VP (VBN lysed)
              (PP (IN with)
                (NP (CD 100) (JJ normal) (NN PBMNC)))))))
      (. .))))

(
  (S
    (S
      (NP (NNP Lane) (NN M))
      (VP (VBD –)
        (NP
          (NP (NN pUC19/HpaII) (JJ molecular) (NN weight))
          (NP (NN marker)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (VBG following) (CD 3) (NNS lanes))
      (VP (VBP are)
        (NP
          (NP (NNS amplifications))
          (PP (IN from)
            (NP (CD 100) (NN PBMNC) (RB only))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (VBG following) (CD 5) (NNS lanes))
        (VP (VBP are)
          (NP
            (NP (NNS amplifications))
            (PP (IN from)
              (NP
                (NP (CD one) (NN MDA-MB-453) (NN cell))
                (PP (IN in)
                  (NP (CD 100) (NN PBMNC))))))))
      (, ,)
      (S
        (NP
          (NP (NNP Lane))
          (NN C))
        (VP (VBZ is)
          (NP (DT the) (NN cDNA) (JJ positive) (NN control))))
      (, ,)
      (S
        (NP (NNP Lane) (NN G))
        (VP (VBZ is)
          (NP
            (NP (DT the) (JJ genomic) (NN DNA) (NN control))
            (PRN (-LRB- -LRB-)
              (NP (NN G))
              (-RRB- -RRB-)))))
      (, ,)
      (S
        (NP
          (NP (NNP Lane))
          (NN R))
        (VP (VBZ is)
          (NP (DT the) (NN RT) (NN –) (JJ negative) (NN control)))))
    (: ;)
    (S
      (NP
        (NP (NNS Lanes))
        (VP (VBN labelled)
          (S
            (NP (NN N)))))
      (VP (VBP are)
        (NP (DT the) (NN PCR) (JJ negative) (NNS controls))))
    (. .)))

(
  (S
    (S
      (NP (JJ Genomic) (NNS bands))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN seen)
            (PP (IN for)
              (NP (JJ many) (NN ELF3) (NNS amplifications)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (NP
        (NP (NN Expression))
        (PP (IN of)
          (NP (CD seven) (NN RT-PCR) (NNS markers)))
        (PP (IN in)
          (NP
            (NP (CD 5) (JJ separate) (JJ single) (NN MCF-7) (NNS cells))
            (VP (VBN lysed)
              (PP (IN with)
                (NP (CD 100) (JJ normal) (NN MNC)))))))
      (. .))))

(
  (S
    (S
      (NP (NNP Lane) (NN M))
      (VP (VBD –)
        (NP
          (NP (NN pUC19/HpaII) (JJ molecular) (NN weight))
          (NP (NN marker)))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (VBG following) (CD 3) (NNS lanes))
      (VP (VBP are)
        (NP
          (NP (NNS amplifications))
          (PP (IN from)
            (NP (CD 100) (NN PBMNC) (RB only))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (VBG following) (CD 5) (NNS lanes))
        (VP (VBP are)
          (NP
            (NP (NNS amplifications))
            (PP (IN from)
              (NP
                (NP (CD one) (NN MCF-7) (NN cell))
                (PP (IN in)
                  (NP (CD 100) (NN PBMNC))))))))
      (, ,)
      (S
        (NP
          (NP (NNP Lane))
          (NN C))
        (VP (VBZ is)
          (NP (DT the) (NN cDNA) (JJ positive) (NN control))))
      (, ,)
      (S
        (NP (NNP Lane) (NN G))
        (VP (VBZ is)
          (NP
            (NP (DT the) (JJ genomic) (NN DNA) (NN control))
            (PRN (-LRB- -LRB-)
              (NP (NN G))
              (-RRB- -RRB-)))))
      (, ,)
      (S
        (NP
          (NP (NNP Lane))
          (NN R))
        (VP (VBZ is)
          (NP (DT the) (NN RT) (NN –) (JJ negative) (NN control)))))
    (: ;)
    (S
      (NP
        (NP (NNS Lanes))
        (VP (VBN labelled)
          (S
            (NP (NN N)))))
      (VP (VBP are)
        (NP (DT the) (NN PCR) (JJ negative) (NNS controls))))
    (. .)))

(
  (S
    (S
      (NP (JJ Genomic) (NNS bands))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN seen)
            (PP (IN for)
              (NP (JJ many) (NN ELF3) (NNS amplifications)))))))
    (. ,)))

(
  (S
    (NP
      (NP (NN Table) (CD 1))
      (: :)
      (NP
        (NP (NN Primer) (NNS sequences))
        (PRN (-LRB- -LRB-)
          (NP
            (NP
              (NP (NN sense))
              (PRN (-LRB- -LRB-)
                (NP (NN s))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (NN anti-sense))
              (PRN (-LRB- -LRB-)
                (ADVP (RB as))
                (-RRB- -RRB-))))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP
          (NP
            (NP (JJ melting) (NNS temperatures))
            (PRN (-LRB- -LRB-)
              (NP (NN Tm))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP (NN annealing) (NN temperature))
            (CC and)
            (NP (VBN expected) (NN product) (NN size))))
        (PP (IN in)
          (NP
            (NP (NNS nucleotides))
            (PRN (-LRB- -LRB-)
              (NP (NN nt))
              (-RRB- -RRB-))))
        (PP (IN for)
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP (DT the) (CD seven) (VBN selected) (NN marker) (NNS genes))))))
      (. .))))

(
  (S
    (NP
      (NP (NN Table) (CD 2))
      (: :)
      (NP
        (NP (NN Comparison))
        (PP (IN of)
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (DT the) (CD seven) (VBN selected) (NNS markers)))
            (PP
              (PP (IN in)
                (NP
                  (NP (DT either) (CD 100) (NNS PBMNCs))
                  (ADVP (RB only))))
              (, ,)
              (CC or)
              (PP (IN after)
                (NP
                  (NP (DT the) (NN addition))
                  (PP (IN of)
                    (NP
                      (NP (DT a) (JJ single) (NN tumor) (NN cell))
                      (PP (IN from)
                        (NP
                          (NP (CD one))
                          (PP (IN of)
                            (NP (CD four) (JJ different) (NN cell) (NNS lines)))))))))))))
      (. .))))

(
  (S
    (NP
      (NP (NN Table) (CD 3))
      (: :)
      (NP
        (NP (NN Profile))
        (PP (IN of)
          (NP (NN gene) (NN expression)))
        (PP (IN from)
          (NP
            (NP
              (NP (CD 10) (JJ different) (NNS experiments))
              (NP (DT each)))
            (VP (VBG using)
              (NP (CD 5) (JJ single) (NN tumour) (NN cell/100) (NN PBMNC) (NNS aliquots))
              (PP (IN from)
                (NP (CD four) (JJ different) (NN cell) (NNS lines)))))))
      (. .))))

